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Abstract 
 
In recent years, the use of encoded beads has received considerable attention due 
to their potential for measuring multiple analytes in solution.(1-4) This can be achieved 
without the need for knowledge of their spatial position, as in the case of microarray 
technology. Encoded bead technology also relies on the solution kinetics rather than 
diffusion to a fixed surface as in the case of microarray technology, offering the possibility 
of developing rapid high throughput screening methods.  
 
This thesis describes the production, characterisation and application of quantum 
dot encoded beads prepared using layer-by-layer assembly of different colour quantum 
dots around a magnetic bead. To achieve this, two different strategies were used to make 
“coloured” barcodes. The first strategy used thiol chemistry to immobilise quantum dots in 
a layer-by-layer assembly onto magnetic beads whereas the second strategy uses the 
interaction between quantum dot-biotin and quantum dot-streptavidin conjugates to 
create constructs on the magnetic bead surface. The development of both of these 
immobilisation strategies was characterisation using X-ray photoelectron spectroscopy and 
fluorescence spectroscopy of immobilised quantum dot structures onto a plain glass 
substrate.  
 
After the preparation of encoded beads, they were characterised using single bead 
fluorescence spectroscopy. It was found that attempts to prepare barcodes by layer-by-
layer assembly of CdSe/ZnS quantum dots using thiol chemistry onto magnetic beads did 
not comply with the necessary barcode characteristics i.e., different colour coded beads 
could not be distinguished from each other. However, the encoded beads prepared using 
layer-by-layer assembly of quantum dot-biotin and quantum dot-streptavidin conjugates 
onto streptavidin coated magnetic beads gave distinct multicolour coded bead spectra. 
These barcodes were characterised in terms of different spectral responses, stability at 
raised temperatures, stability in biotin solutions, and long-term stability after storage. 
 
Encoded beads prepared using layer-by-layer assembly of quantum dot-biotin and 
quantum dot-streptavidin conjugates onto streptavidin coated magnetic beads were then 
used to develop multiplexed immunoassays. Four different barcodes were prepared and 
used to perform model multiplexed immunoassays. The barcodes were identified upon the 
basis of different spectral response measured using single bead fluorescence spectroscopy. 
Finally, a quantitative immunoassay for human IgG was performed using these barcodes, 
which showed that different concentrations of human IgG can be determined in solution.  
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Chapter 1 
 
Introduction and Review of Literature 
 
 
 
 
 
 
 
 
 
In this chapter, a brief introduction to biosensing technologies is presented and 
different methods for producing barcodes are described. In this context, barcode 
production is divided into different categories namely: lithographic approaches for 
barcode fabrication; microfluidic production of barcodes; graphical encoding; encoding 
based on Raman and Infrared signatures; physical encoding; chemical encoding; barcoded 
fluorescent beads. An overview of each category is presented. A section detailing 
biosensing applications of barcodes is also described. At the end of the chapter, the 
concept behind the studies presented in this thesis is introduced. 
 
1.1. Introduction  
 
The convergence of materials science and biology has emerged as a new and 
exciting field of research known as nanobiotechnology which has resulted in the 
development of novel analytical tools with promising applications in the environment, 
health and industrial sectors.(1, 2) To meet the growing challenges of healthcare in this era 
of nanotechnology, the demands of biological sensing have continually increased over the 
last two decades. The treatment of many health symptoms often requires an accurate, 
reliable and faster diagnosis. Biosensors can be used for the detection and quantification 
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of many different biological target analytes, such as DNA, RNA, immunoglobulins and many 
other molecules of interest related to different diseases.  
 
A biosensor consists of biological sensing elements such as enzymes, DNA, 
antibodies, cells and tissues, immobilised or retained on a sensor or transducer surface. (3, 
4) Biosensors can be classified depending on the nature of the biological sensing elements 
and type of the transducer. Several books and review articles can be found on this topic 
covering a range of different types of biosensors and their applications.(4-10)  
 
1.2. Biosensors 
 
As mentioned above biosensors comprise two parts i.e biological sensing element 
and sensor or a transducer. Following is a brief introduction to some of the biological 
sensing elements and transduction techniques.   
 
1.2.1. Biological Sensing Elements  
 
The biological sensing element can be classified into five major categories, namely 
DNA, antibodies or antigens, enzymes, cells and biomimetic materials.(3) The specificity 
and selectivity of the biological sensing element plays a key role in the development of a 
biosensor: for example biosensors used for the determination of DNA hybridisation utilise 
highly specific single stranded probe DNA immobilised on the sensor to detect a particular 
DNA sequence. This information which arises due to the precise nature of Watson-Crick 
bonding, could be used for the detection of tumours, genetic disorders, pathogenic 
bacteria and viruses.(11)  
 
Biosensors produced by using enzymes as the biological sensing element are based 
on the catalytic reaction in the presence of a particular substrate. For example in the case 
of a glucose biosensor, glucose oxidase (an enzyme) is immobilised on the transducer and 
in the presence of oxygen catalyses the conversion of D-glucose into D-gluconic acid and 
hydrogen peroxide which can then be determined using different strategies.(12) Different 
enzymes have been used as a biological sensing element to produce biosensors for the 
determination of glucose,(13-16) ascorbic acid, (17, 18) cholesterol,(19, 20) choline,(21) ethanol,(22) 
, for example.  
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Antibodies or antigens also are used as the biosensing element because of their 
capability to bind to a specific structure. An antibody or immunoglobulin binds to its 
antigen in a lock and key (or “hand in glove”) mechanism.(3) When an organism is exposed 
to a foreign antigen, B cells produce immunoglobulins in response to the antigen. 
Immunoglobulins have unique antigen binding sites that recognise the antigen.(23) 
Immunoglobulins can be divided into five major types IgM, IgG, IgA, IgE and IgD.(24) Each of 
these immunoglobulins has different characteristics, which helps the immune system to 
response against different antigens in different conditions throughout the body.(24) 
 
 Immunoglobulins or antibodies have a Y shaped structure, which consists of two 
main structural regions namely, the variable region or antigen binding site and the Fc 
region. The variable region or antigen-binding region specifically binds with an epitope on 
an antigen and the Fc portion is responsible for the clearance of antigen from the body 
and to promote immune response.(25) Figure 1-1 shows the structure of Immunoglobulins 
(variable region and Fc region), which consists of two identical light chains and two heavy 
chains held together by disulphide bonds.(26) Enzymatic cleavage of IgG with papain yields 
two Fab and one Fc fragments by breaking at hinge region.(25, 27)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1: Schematic of an Immunoglobulin. -S-S- shows disulphide bridge. 
 
 
Light chain 
region 
Fab 
Fc 
Heavy chain 
region 
Antigen binding 
site 
Hing-region 
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Antibodies or immunoglobulins can either be monoclonal or polyclonal in nature 
depending on the method of production. “A monoclonal antibody is defined as a uniform 
homogeneous antibody directed at a single epitope or antigenic determinant and produced 
continuously from one cell clone”(28) whereas polyclonal antibodies are produced by 
immunisation across animal species or within species.(25, 27, 28) Polyclonal antibodies have 
certain disadvantages when used in assays like batch-to-batch variation in the specificity 
and reactivity, variation in specificity and reactivity among antibodies within an 
antiserum.(28) Different immunosensors have been developed using Immunoglobulins or 
antibodies due to their specific affinity for antigens.(29-31)  
 
1.2.2. Transduction Techniques 
 
A transducer or sensor translates the biological event as a result of the interaction 
of biological sensing element with the analyte into a measurable signal. There are many 
types of sensors which include electrochemical, optical and piezoelectric, for example.(3) 
However, in this section only electrochemical and optical transducers are discussed 
briefly.  
 
Electrochemical transducers convert the biological recognition event into a useful 
electrical signal.(32) Commonly used electrochemical transducers are amperometric and 
potentiometric sensors. Amperometric transducers are based on the application of a 
constant potential and “monitoring the current associated with the reduction or oxidation 
of an electroactive species involved in the biological recognition process”.(32) In contrast, 
in the case of potentiometric transducers, the change in potential is used as the measure 
of the occurrence of events due to the biological sensing element-analyte interaction.(32) 
Electrochemical transducers have been used for applications in enzyme based 
biosensors,(33) DNA hybridisation,(34, 35) DNA damage detection (36) and immunoassays.(37, 38) 
 
Optical transduction technologies rely on the measurement of photons or photonic 
interactions rather than electrons as in the case of electrochemical transducers.(39) More 
common optical transduction methods are based on absorbance, reflectance, 
fluorescence, infrared and Raman.(39) Optical transduction using fluorescence has gained 
most attention due to its high specificity and sensitivity in the detection of different 
target molecules.(40) In the context of this thesis fluorescence is discussed in detail.  
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The fluorescence of a molecule is the light emitted spontaneously due to 
transitions from excited singlet states (usually S1) to various vibration levels of the 
electronic ground state, i.e. (S1,0 to S0,ν)(41) as shown in Figure 1-2. Fluorescence can be 
characterised using fluorescence intensity at a given wavelength i.e emission spectrum, 
quantum yield, lifetime and polarisation.(41) A fluorescence emission spectrum is a plot of 
fluorescence intensity versus wavelength (nanometers) or wavenumber (cm-1). (42)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-2: Jablonski diagram showing the mechanism for fluorescence emission, 
taken from (43). Reproduced with permission. Copyright © 1996 by Dr. Thomas G. 
Chasteen. 
 
 
 
Fluorescence typically occurs from aromatic molecules usually called fluorophores 
or fluorescent dyes. Different fluorescent dyes have been used in different biosensor 
formats for biological applications.(22, 44, 45)  However, in addition to the organic 
fluorophores or fluorescent dyes, semiconductor nanocrystals called quantum dots also 
exhibit fluorescent properties that have been used in many applications.(46, 47)   
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1.2.3. Quantum Dots 
 
Quantum dots are highly luminescent and monodisperse nanocrystals (CdSe/ZnS or 
CdTe, for example) that are currently of great interest especially due to their use as labels 
in bioanalytical applications.(48) Quantum dots are often composed of atoms from group II-
VI or III-V elements in the periodic table, and are defined as particles with physical 
dimensions smaller than the exciton Bohr radius.(49)  
 
Quantum dots offer good photostability, high fluorescence intensity and broad 
tunability that make these an excellent choice as a chromophore.(50) Different methods of 
synthesis of quantum dot nanocrystals have been reported but the formation of quantum 
dots in colloidal form via solution chemistry is an easy and successful route to realise 
quantum dots.(51-55) Quantum dot emission wavelengths are dependent on the size of the 
quantum dots.(55, 56) Different sizes of quantum dot nanocrystals give a different spectral 
response. Figure 1-3 shows the dependence of emission spectra with the size of the 
quantum dots and biomolecules functionalised CdSe/ZnS quantum dot.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-3: (a) Shows emission spectra of different quantum dots, taken       
from (57); (b) Biomolecules conjugated quantum dot (not to scale), reproduced 
from (58).   
 
ZnS 
CdSe 
Polymer  
coating 
Biomolecule 
(b) (a) 
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The surface properties of the quantum dots can be easily manipulated by the 
addition or removal of organic functional groups during a chemical synthesis without 
altering the intrinsic optical properties.(59) Quantum dots functionalised with different 
biomolecules (streptavidin, biotin, oligonucleotides or peptides, for example) have been 
used as fluorescent labels in many applications. Examples include immunoassays and DNA 
assays.(60-62)   
 
1.3. Barcode Technology for Biological Sensing 
 
Particular to the biological detection, a large number of materials and assays have 
been developed to detect and quantify different biomolecules including for example 
antigens, antibodies, and nucleic acid sequences related to different diseases. The 
detection of these biomolecules may require the measurement of more than one analyte 
at the same time, in a sample. This need has led to the development of multiplexed assays 
to detect biomolecules.  
 
Microarray technologies, including those associated with proteins, RNA and DNA 
are the most popular approaches for analysing hundreds of targets in parallel.(63) However, 
the development of barcoded beads or lithographically encoded particles has open up new 
possibilities for multiplexing analysis of biomolecules. This technology has the potential to 
replace microarray technology by overcoming some of their limitations. For example, in 
optical microarray technology, a large number of different biomolecular binding events 
can be identified from their characteristic response and their position on a two-
dimensional grid, a technology that has become synonymous with high density 
screening.(64) A variety of methods have been proposed for such assays, including the use 
of fluorescent dyes and quantum dots. The very nature of the microarray, however, often 
results in relatively slow reaction events; as a consequence, the geometry of the chip and 
mass transfer limit transduction at a solid surface, Figure 1-4a. 
 
In contrast, tags based upon either micrometer- and nanometer-dimensioned 
encoded particles, known as barcodes, provide a technique that can perform many 
hundreds of individual tests in parallel, in solution(65), without the need for a knowledge of 
their spatial position on a chip, Figure 1-4b. These barcodes may benefit from better 
solution kinetics, high surface to volume ratios, as well as robust assay modification and 
development of high throughput screening methods.(66) 
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Current techniques used to fabricate such barcodes range from using elegant 
solution chemistries to assemble fluorescent dyes or quantum dots, to the application of 
highly sophisticated and relatively expensive lithographic techniques to make patterned 
structures (e.g. using UV or electron beam lithography).(67) Depending upon the basis of 
the encoding strategy used, barcodes have generally been created with an optical signal 
transduction technique, as the assay can be read out in parallel. Current techniques may 
include fluorescence, Surface Enhanced (Resonance) Raman Scattering, SE(R)RS), 
scattering or reflectivity.  
 
 
 
 
 
 
 
 
 
 
Figure 1-4: (a) Shows a microarray platform, which uses positional encoding for 
multiplexed analysis; (b) Barcoded beads labelled with different recognition 
molecules (antibodies, DNA or RNA sequence), taken from (63). Copyright 
Wiley-VCH verlag GmbH & Co. KGaA. Reproduced with permission. 
 
 
 
A number of different strategies have been used for the production of barcodes. 
Broadly these can be classified as lithographic and different non-lithographic strategies. As 
stated, most of the barcodes produced involve optical methods as detection technique. 
 
1.3.1. Lithographic Approaches for Barcode Fabrication 
 
 Encoded microparticles have been fabricated using a combination of different 
techniques that include “photolithography, lift-off, electroplating-through-mask, metal 
thermal evaporation, and wet etching processes.” (68) Figure 1-5 shows the sequence of 
steps used to fabricate the encoded microparticles. Here, the thickness (~2µm) of the 
particles was controlled by the current density and duration of electrodeposition.  
(a) (b) 
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The coding pattern and dimensions (100 × 200 µm) of the particles in Figure 1-5 
were defined by a photomask. A pattern of 1-10 dots was used as the coding element and 
two dots were fixed at the starting and ending points in order to define the coding area.(65) 
The authors reported that this coding scheme has the potential for 28 = 254 types of 
particles. The level of multiplexing could be increased exponentially by increasing the 
number of dots and their arrangement in the pattern. These encoded microparticles were 
used to register and identify the biomolecules attached to the barcode surface.(65, 68) 
 
 
 
 
 
 
 
 
 
 
Figure 1-5: Shows the sequence of steps for the fabrication of encoded 
microparticles. “SU-8 photoresist was first photolithographically patterned as the 
particle template on a Cu-coated glass substrate; Ni-PTFE (electroplating solution 
containing nickel sulfamate and fine polytetrafluoroethylene particles) layers (~6 
μm thick) were electrodeposited on the open areas of the photoresist-patterned 
microwells. After evaporation of Cr (20 nm) and Au (300 nm) from the whole chip 
surface, metallised SU-8 photoresist was lift-off using SU-8 remover. Finally, the 
particles were released from the underlying substrate by dissolution of the Cu 
sacrificial layer.” Reprinted With permission from (68). Copyright © 2003 
American Chemical Society. 
 
 
 
Using a different approach, micron-scale freestanding porous silicon photonic 
crystal particles containing spectral barcodes have been fabricated by using standard 
photolithographic process and electropolishing.(69) “An electrochemically prepared film of 
porous silicon on a crystalline silicon substrate was patterned with an SU8-25 
photoresist.”(69) The mask used was a square array of circles, each 25µm in diameter with 
a pitch of 35µm and the unmasked porous silicon was removed with reactive ion etching 
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process. Electropolishing was used to remove the porous microparticles formed.        
Figure 1-6 shows the scheme used to fabricate these encoded microparticles along with 
the image and reflection spectra of a microparticle. The encoding capacity of this process 
was estimated to be ~104 microparticles from a 1.33 cm2 wafer surface.(69) 
 
Silicon microbeads have also been fabricated by using standard microfabrication 
techniques that can be identified on the basis of their different optical signatures.(70) 
Although the barcodes were fabricated with distinctive optical signatures their dimensions 
were large (1000 μm×500μm ×100μm).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-6: (A) Shows the process of preparing microparticles from a spectrally 
encoded porous silicon film, (a) first a photopattern was fabricated, (b) porous 
silicon was etched by using plasma etching and (c) finally photoresist was 
removed and particles were released; (B) Reflection spectrum of a single porous 
silicon microparticle; (C) SEM images of microfabricated porous silicon photonic 
crystal particles, taken from (69). Copyright Wiley-VCH verlag GmbH & Co. KGaA. 
Reproduced with permission. 
 
 
 
Finally, Electron beam lithography and nanoimprint lithography have been used to 
fabricate barcoded beads of SU8 photoresist.(71, 72) These barcodes are based on different 
(A) (B) (C) 
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grating structures created on an SU8 surface that allow distinguishing via diffraction 
properties. Figure1-7 shows an array of nanoimprinted SU8 microbarcodes. In this case, 
SU8 bars were pre-fabricated using a standard lithography protocol and electron beam 
lithography or nanoimprint lithography were used afterwards to make grating structures in 
the SU8 bars.(71, 72) It was estimated that approximately 109 barcodes could be produced on 
a 50µm long barcodes.(71) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-7: (a) “Schematic of the process for manufacturing nano-embossed SU8 
microbars. An Al sacrificial layer and a layer of SU8 are spun onto a Si wafer (1–
3). The SU8 is illuminated with UV light through a mask to cross-link the SU8, and 
uncross-linked SU8 washed away to leave the microbars (4 and 5). The nano-
embossing stamp is pressed into the SU8 to pattern it (6 and 7), with baking 
during step 7. Finally the patterned bars are released (8) by etching away the Al 
layer”(72); (b) SEM images of barcode tags prepared by nanoimprint lithography, 
taken form(72). Copyright ICP Publishing Ltd. Reproduced with permission. 
 
 
 
1.3.2. Microfluidic Production of Barcodes 
 
Continuous flow lithography approaches have also been used to fabricate encoded 
particles.(73) These approaches involved adjacent flow of two monomers through a 
(a) (b) 
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microfluidic channel (Figure1-8). In the experiment, one monomer was loaded with a dye 
and the second monomer was an acrylate modified probe. The continuous-flow lithography 
technique was used to polymerise these monomers as they passed through the channel. 
The advantage of this approach is that the morphology and chemistry of each particle can 
be controlled both by using a photomask and by changing the composition of the flowing 
monomer streams, respectively. The encoding capacity for these barcodes was reported 
over a million (220) codes.(73) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-8: (a) Shows the schematic diagram for the preparation of dot-coded 
particles; (b) Microscopic image of the particles prepared in scheme a. Scale bar 
is 100μm; (c) Diagram shows different regions of the dot-coded particle; (d) 
Fluorescence intensity measured on a dot-coded particle, taken from (73). 
Reprinted with permission from AAAS. 
 
 
 
Photonic crystal hydrogel beads have been prepared by generating droplets of 
monodisperse silica nanoparticles in poly (ethylene glycol) diacrylates (PEG-DA) using a 
microfluidic device.(74) These droplets were then irradiated with UV-light to polymerise the 
hydrogel. The silica nanoparticles were trapped in the hydrogel network and give photonic 
crystal features, which have different optical reflectivities (Figure 1-9).  
(a) (b) 
(d) 
(c) 
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Figure 1-9: (a) shows the set-up for the production of photonic crystals using a 
microfluidic device; (b) The reflection spectra of different photonic crystal 
hydrogel beads, taken from (74). Reproduced by permission of The Royal Society 
of Chemistry. 
 
 
 
The barcodes prepared using lithographic and microfluidic techniques have high 
encoding capacity. However, the size of the barcode produced is large, typically 
50-200um. Moreover, the applications of these barcodes for a multiplexed bioassay require 
multiple separation and washing steps. Often this is done by centrifugation of the barcodes 
prepared using lithographic and microfluidic approaches, however magnetic separation can 
be a more convenient and faster method.  
 
1.3.3. Graphical Encoding 
 
Graphical encoding relies on the physical properties of the barcoding element.(63) 
For example, glass barcodes containing patterns of different fluorescent materials have 
been fabricated in micrometer dimensions. These materials can be identified by using 
their unique fluorescent signatures when excited with a UV lamp.(75) RE (Rare earth)-doped 
alkaline earth aluminosilicate glass compositions for a particular colour were mixed, and 
optimal doping levels were obtained by maximising the relative fluorescence intensity as a 
function of the RE (RE2O3) concentration. This product was drawn out into a ribbon fiber 
(20 μm thick, 100 μm wide), which was cut into 20μm sections at a rate of 5 mms-1 with 
800-nm femtosecond laser pulses (100mW average power) on a computer-controlled 
stage(63, 75) (Figure 1-10).   
(a) (b)
    
 
 
22 
 
 
 
 
 
 
 
 
 
 
Figure 1-10: (a) White light image of micron size glass rods encoded with 
different fluorescent rare-earth ions; (b) Fluorescence image of (a) when excited 
with UV-light and using a 420 nm long pass filter, taken from (75). Copyright 
(2003) National Academy of Sciences, U.S.A. 
 
 
 
In another method different metals (Pt, Pd, Ni, Co, Ag, Cu, and Au) were 
incorporated as segments of a micro- or nanorod like structure by sequential 
electrochemical deposition of metal ions into uniformly sized pores using Al2O3 membrane 
as a template(76) (Figure 1-11). Optical microscopy was used to identify the stripped 
patterns based upon the metal’s reflectivity. Protein and DNA bioassays performed using 
these barcodes showed that the readout mechanism did not interfere with the analyte 
detection using fluorescence.(76) 
 
1.3.4. Encoding Based on Raman and Infrared Signatures 
 
Raman and Infrared (IR) spectroscopic signatures of different molecules have been 
utilised to produce barcodes. Su et al.,(77) “prepared a new type of barcodes called 
composite organic-inorganic nanoparticles (COINs). The method allows the incorporation  
of a broad range of organic compounds into COINs to produce a large number of surface 
enhanced Raman scattering (SERS)-like signatures,”(77) as shown in Figure 1-12.  
 
Fenniri et al.,(78) synthesised different barcode resins that have infrared (IR) and 
Raman spectroscopic signatures using different styrene derivatives. Only 24 unique codes 
were reported using the unique vibrational signatures of all the six derivatives.  
(a) (b) 
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Figure 1-11: (a) Synthesis of barcode particles; (b) Reflectance optical 
microscopy images and line profiles for a particle of composition Au-Ag-Ni-Pd-Pt 
with illumination at 430 nm, 520 nm, and 600 nm, respectively, taken from (76). 
Reprinted with permission from AAAS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-12: (a) Scheme showing aggregation of seeded silver nanoparticles and 
raman labels in silver nitrate solution to produce coins; (b) and; (c) Shows coins 
prepared by using single raman dye label and multiple labels in one coin. Where 
AA= 8-azaadenine, AN=9-aminoacridine and MB= methylene blue. The arrows 
show representative peaks from three different dyes. Reprinted With permission 
from (77). Copyright © 2003 American Chemical Society. 
(a) (b) 
(a) (b) (c) 
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1.3.5. Physical Encoding 
 
Physical encoding relates to the shape and size of the barcodes that interact with 
light differently. A photo-induced method for converting silver nanospheres into triangular 
nanoprisms has been developed.(79) Figure 1-13 shows the change in UV-Vis spectra due to  
the change in shape and size of the particles.(79) This approach has been used to synthesize 
a distinct number of barcodes that can be identified in a multiplexing assay.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-13: (A) “Time-dependent UV-Vis spectra showing the conversion of 
silver nanospheres to nanoprisms (a) before irradiation and after (b) 40, (c) 55, 
and (d) 70 hours of irradiation; (B) Corresponding extinction profiles at 670 nm as 
a function of time. TEM images mapping the morphology changes (C) before 
irradiation and after (D) 40; (E) 55; (F) 70 hours of irradiation. Except for the 
inset in (C), the scale bar is 200 nm for all four images,” taken from (79). 
Reprinted with permission from AAAS. 
 
 
 
C D 
E F 
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1.3.6. Chemical Encoding 
 
Quantum dot nanobarcodes have been prepared by using quantum dot copolymer 
complexes. These complexes grow into nanobeads of narrow size distribution.(80) First, the 
quantum dots were precoated with poly(maleic anhydride-octadecene) (PMAO) via 
hydrophobic interaction. By increasing the solvent polarity, uniform quantum dot 
nanobeads were formed as shown in Figure 1-14.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-14: (a) Shows schematic of nanobeads formation; (b) TEM image of the 
nanobeads (upper) showing the size of the nanobeads 92±13 nm and fluorescence 
image of the nanobeads (lower), Reprinted With permission from (80). Copyright 
© 2008 American Chemical Society. 
 
 
 
Another oligonucleotide based barcoding technology has been developed which 
utilises colour coded oligonucleotide probe pairs as an encoding strategy. The technology 
named as “Nanostring technology” uses capture probe and reporter probe for 
multiplexing. (81) The reporter probe contains different fluorescent dyes that encode a 
particular sequence, which results in barcoding of multiple sequences, Figure 1-15. 
 
The barcode production strategies described above (Sections 1.3.3 to 1.3.6) have 
different advantages and disadvantages. For example, in case of graphical encoding, the 
size of the barcode is large (20μm) while the encoding speed is high. The barcodes  
(a) (b) 
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Figure 1-15: “Overview of NanoString nCounter gene expression system: (a) A 
schematic representation of the hybridised complex (not to scale). The capture 
probe and reporter probe hybridise to a complementary target mRNA in solution 
via the gene-specific sequences; (b) Schematic representation of (i) binding of 
purified complexes to a streptavidin-coated slide, (ii) electrophoresis, and (ii) 
immobilisation of reporters for imaging and counting; (c) False-colour image of 
immobilised reporter probes,” taken from (81). Reprinted by permission from 
Macmillan Publishers Ltd. 
 
 
 
produced using Raman and Infrared signatures, give a better control over identification of 
the barcodes. However, the barcoding capacity of these methods depends on the 
availability of number of different organic molecules that have distinct Raman or infrared 
signatures. 
 
In the case of physical encoding methods, barcodes are produced on the basis of 
size and shape resulting in the limited number of barcodes that can be produced. 
Moreover, within one type of barcode, the variation in size and shape can influence the 
identification of the barcode. Encoding strategies based on quantum dot co-polymer 
complexes can be useful to produce nanobarcodes, however, the lack of control over the 
size of the barcode and number of different quantum dots within one barcode results in 
higher variations. This influences the number of unique quantum dot barcodes that can be 
produced using this method. In case of oligonucleotide-based barcoding strategy, which 
relies on the use of different fluorescence dyes within one barcode. In order to identify 
(a) 
(b) 
(c) 
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these barcodes, each fluorescent dye needs to be excited with a particular excitation 
wavelength within a barcode. This increases the measurement time and places more 
demands on the readout instrumentation. The encoding strategy based on the barcoded 
fluorescent beads offer a wide variety of methods for producing encoded beads and also 
have the potential of incorporating multiple functionalities such as magnetic bead based 
barcodes.  
 
1.3.7. Barcoded Fluorescent Beads 
 
The production of barcoded fluorescent beads can be classified into three 
different methods(82) namely: barcoded beads produced by the encapsulation of quantum 
dots or dyes into the beads; Incorporation of quantum dots during the synthesis of beads; 
and immobilisation of quantum dots or fluorescent dyes on the bead surface.  In these 
methods, the beads act as carrier elements that host the quantum dots or fluorescent dyes 
and which act as the encoding element.  
 
In the case of encapsulation, beads were first swelled in an organic solvent in the 
presence of encoding nanoparticles (e.g., quantum dots) or molecules (fluorescent dyes). 
Due to the swelling of the beads, nanochannels or nanopores were opened on the bead 
surface and allowed quantum dots or dye molecules to enter the pores. When these beads 
were placed in an aqueous solution, this closes the opened channels resulting in 
encapsulation of the quantum dots or dye molecules into the beads.(83) These beads 
provide an inert environment to the coding elements and prevent aggregation with their 
neighbours.(83, 84)  
 
In the second approach, quantum dots were first dispersed in the monomer 
solution and then initiator was added to form the beads encapsulated with quantum 
dots.(85) Thirdly, quantum dots or fluorescent dyes were immobilised on the bead 
surface.(86) The encoding elements used in these approaches consisted of fluorescent dyes, 
chromophores and quantum dots. By trapping different dyes or quantum dots onto a bead, 
distinctive spectral barcodes can be produced. The number of barcodes depended upon 
the number of dyes or quantum dots and “intensities according to the formula: C= Nm-1 
(where C is the number of codes, N is the number of intensity levels and m is the number 
of colours).”(84) 
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Quantum dots are superior to fluorescent dyes as an encoding element because of 
unique optical properties(49) and have several advantages over the fluorescent dyes. These 
advantages that they exhibit are: significantly less photobleaching as compared to 
fluorescent dyes; greater encoding capacity as a consequence of less spectral overlap 
between the symmetric and spectroscopically narrow fluorescence emission; excitation by 
a single, low wavelength excitation source which also gives a brighter signal placing less 
demand on detection equipment (Figure 1-16).(73, 87) 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
Figure 1-16: (A) Ten different coloured CdSe/ZnS quantum dots excited with a 
UV-lamp give different emission maxima (from left to right at 443, 473, 481, 500, 
518, 543, 565, 587, 610, and 655 nm); (B) Comparison of (a) the excitation and 
(b) the emission profiles of rhodamine 6G (red) and CdSe/ZnS QDs (black), taken 
from(49). Reprinted with permission from Elsevier. 
 
 
 
1.3.7.1. Encapsulation of Quantum Dots into the Beads 
 
Based on the above advantages of the quantum dot nanocrystals, Han et al.,(84) 
developed barcodes using polystyrene beads as a ‘cargo’ and quantum dots as the 
encoding elements. Figure 1-17 represents the encoding principle to produce multicolour 
(A) 
(B) 
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encoded beads using quantum dots as encoding elements. The authors suggested that the 
number of codes can be increased exponentially by using multiple wavelengths and 
intensities of the encoding elements. For example, one million barcodes can be generated 
by using six colour and ten intensity levels. However, practical encoding capacity is lower 
because of spectral overlapping, optical intensity variations, and “signal-to-noise” 
requirements.(84) 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 1-17: (a) Schematic diagram of optical coding based on wavelength and 
intensity multiplexing. On the left large spheres represent polystyrene beads 
embedded with quantum dots (small spheres); (b) Fluorescence micrograph 
showing a mixture of single colour encoded polystyrene beads, taken from (84). 
Reprinted by permission from Macmillan Publishers Ltd. 
 
 
 
In another approach multicolour encoded microspheres were produced by 
incorporating CdTe nanocrystals with different sizes into N-isopropylacrylamide and 4-
vinylpyridine co-polymer hydrogel spheres by utilising their stimuli responsive swelling 
properties.(88) This co-polymer swelled at pH 3 and took up the quantum dots. The hydrogel 
spheres shrunk at a higher pH to incorporate the quantum dots (Figure 1-18).  
(a) (b) 
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Figure 1-18: (a) Schematic illustration of quantum dot encapsulation; (b) 
Fluorescence images of hydrogel spheres and corresponding fluorescence spectra 
of the hydrogel spheres, taken from (88). Copyright Wiley-VCH verlag GmbH & 
Co. KGaA. Reproduced with permission. 
 
 
 
Thiol (-SH) containing polystyrene beads have also been used to prepare barcodes 
by the incorporation of quantum dots through a swelling/doping strategy.(89) It was found 
that these barcodes were highly stable against leaching of quantum dots into different 
solvents due to the thiol-quantum dot interaction.(89) Mesoporous polystyrene beads were 
used to encapsulate quantum dots.(90) It was reported that the mesoporous beads were 
~1000 times brighter than the same size non-porous beads of similar composition due to 
high loading and even distribution of quantum dots within the beads.(90) 
 
Quantum dots were encapsulated in the polymer matrix like poly(styrene-co-
maleic anhydride) to prepare quantum dot barcodes. Quantum dots were mixed with 
poly(styrene-co-maleic anhydride) in the presence of chloroform to make a homogeneous 
suspension of the quantum dots.(91) This solution was introduced into a nozzle system using 
a syringe pump along with water as a focusing fluid that intersect at the nozzle output, 
Figure 1-19. The polymer suspension was insoluble in water, which solidify the quantum 
dot polymer mixture into water making the barcodes. 
 
Dual function bead based barcodes were produced by simultaneous or sequential 
incorporation of quantum dots and magnetic iron oxide nanoparticles into mesoporous 
silica, (Figure 1-20).(92) It was reported that the sequential and simultaneous doping  
(a) (b) 
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Figure 1-19: (a) Shows barcode production process. An enlargement shown on 
the right shows the working of the flow-focusing nozzle. The quantum dot 
mixture is introduced from the top and the flow focusing fluid is introduced from 
the right; (b) Shows fluorescence images of different barcoded beads along with 
their spectra, taken from (91). Copyright Wiley-VCH verlag GmbH & Co. KGaA. 
Reproduced with permission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-20: (a) Shows two different doping strategies of quantum dot and iron 
oxide nanoparticles into mesoporous beads; (b) The effect of iron oxide 
nanoparticles concentration on fluorescence intensity of barcodes. Reprinted 
With permission from (92). Copyright © 2006 American Chemical Society. 
 
(a) (b) 
(a) (b) 
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produced the same results in terms of optical and magnetic properties of the barcoded 
beads.(92) However, the fluorescence intensity of barcoded beads depended on the amount 
of iron oxide nanoparticles inside the bead. As the number of iron oxide nanoparticles 
increases, the fluorescence intensity decreases. Moreover, the variation in the 
fluorescence intensity ratio of green and red colour quantum dot encoded beads was found 
to be 15% and magnetic beads take 5 min to separate from the solution.(92)  
 
1.3.7.2. In-Situ Incorporation of Quantum Dots into Polymer Beads 
 
 In this strategy, barcoded beads are synthesised in the presence of quantum dots 
and starting monomer for the beads. Polystyrene beads encoded with CdS quantum dots 
were prepared by suspension polymerisation in the presence of CdS and styrene 
monomer.(93) Using this approach different sizes of barcoded beads can be prepared but 
the variation in fluorescence intensity from bead to bead is high as compared to other 
methods due to the variation in the size of the beads and number of quantum dots 
incorporated.(94) 
  
1.3.7.3. Immobilisation of Quantum Dots on Bead Surface 
 
Quantum dots have been immobilised onto the beads and nanoparticles by 
covalent bonding or electrostatic interaction.(95-98) Amphiphillic copolymer coated quantum 
dots were immobilised onto layer-by-layer polyelectrolyte coated beads to produce 
barcoded beads, as shown in Figure 1-21. In these studies, the relative standard deviation 
between the barcodes was found to be 20-22% for three different barcodes.(96)  
 
Magnetic beads have been used as a support for immobilisation of quantum dots by 
first coating the beads with polyamine and then quantum dots were assembled on the 
bead surface.(98) Finally beads were coated with silica nanoparticles, which serve as a 
support in functionalising quantum dot encoded beads for multiplexed applications.(98) 
Silica colloidal crystals beads were encoded with quantum dots using layer-by-layer 
assembly of poly(allylamine hydrochloride), poly(sodium 4-styrenesulfonate) and CdTe 
quantum dots.(99) A large number of barcodes could be generated using this method 
although the barcode size was relatively large i.e. 200μm.  
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Figure 1-21: Shows the strategy for the preparation of quantum dot barcodes 
using polyelectrolyte layer-by-layer assembly, taken from (96). Copyright 
Wiley-VCH verlag GmbH & Co. KGaA. Reproduced with permission. 
  
 
 
1.4. Applications of Barcodes in Multiplexing Bioanalysis 
 
Many of the barcodes, which are discussed in Section 1.3 of this chapter, have 
been used to develop multiplexed bioassays including immunoassays and nucleic acid 
hybridisation assays. For example, polystyrene beads encoded with quantum dots were 
used for multiplexed hybridisation assays as shown in Figure 1-22.(84) Single bead 
fluorescence spectroscopy was used to read the barcodes and to detect different DNA 
sequences. 
 
Similarly sub-micron mertallic nanorods,(100) photonic crystal hydrogel beads,(74) 
quantum dot coated silica encoded beads,(101) dot coded particles prepared by flow 
lithography(73) and spectrally encoded porous SiO2 photonic crystals(102) have been used for 
multiplexed DNA hybridisation. 
 
Barcodes prepared by different strategies have also been used for developing 
multiplexed immunoassays. In an immunoassay antibodies are used as an analytical 
reagent due to their high binding affinity and specificity for the analyte of interest 
(antigen) in the presence of many other substances in a sample.(103, 104) Immunoassays are 
of different formats as shown in Figure 1-23.(39)  
    
 
 
34 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-22: Shows the multiplexed DNA hybridisation assay where three 
different quantum dot encoded beads based barcodes were used to detect three 
different DNA sequences. The results showed that each sequence could be clearly 
identified using this encoding strategy, taken from (84). Reprinted by permission 
from Macmillan Publishers Ltd. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-23: Shows different formats of immunoassays. The upper panel 
shows the situation before immunobinding and lower panel shows the 
situation after immunobinding. Reprinted With permission from (39). 
Copyright © 2008 American Chemical Society. 
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In the case of direct immunoassay, both antigen and antibody are not labelled and 
the binding event is measured using interferometric or electrochemical methods.(39, 105) In 
case of competitive immunoassay, both labelled and unlabelled antigens compete for 
limited number of binding sites(106) whereas in a sandwich immunoassay antigen is first 
captured using an immobilised antibody and a second labelled antibody is used to detect 
the bound antigen.(107, 108)    
 
In the displacement immunoassay format an antibody coated surface is first 
saturated with a labelled antigen and after the introduction of the unlabelled antigen, 
displacement of the labelled antigen occurs resulting in the decrease in fluorescent signal 
of labelled antigen.(39, 109) The response time in these type of assays is slow. (109) 
 
In a binding inhibition immunoassay format an immobilised antigen is used instead. 
The binding of the fluorescently labelled antibody is inhibited due to the binding of the 
antigen present in the solution.(39) The more the antigen present in the solution, the fewer 
antibodies bind to the antigen surface.  
 
In a multiplexed immunoassay, more than one analyte (antigen) is determined 
simultaneously in a sample. Encoded silica colloidal crystal beads have previously been 
used for the multiplexed immunoassay.(110) Three different kinds of silica colloidal crystal 
beads that can be distinguished upon the basis of different reflection spectra were used to 
immobilise three different immunoglobulins (human IgG, mouse IgG and rabbit IgG) for the 
immunoassay. Only two FITC labelled goat anti-human IgG and goat anti-mouse IgG were 
used in the analyte solution and it was shown that these FITC-labelled anti-IgGs bound to 
the corresponding IgGs immobilised on the encoded colloidal crystal beads (Figure 1-
24).(110) 
 
Similarly, different immunoglobulins (mouse, human, rabbit and guinea pig IgGs) 
were immobilised on diffractive microbarcodes of SU8 photoresist and multiplexed 
immunoassays were performed to show multiplexing capability of these barcodes.(64) In 
another study, pearl pigments were incorporated into polystyrene beads using droplet 
generation technique to produce multicolour polystyrene beads. These beads with 
different spectral characteristics were used to do multiplexed immunoassay using different 
antigen-antibody pairs.(111) Finally, quantum dot encoded beads prepared by using 
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poly(styrene-co-maleic anhydride) polymer(91) were used to develop multiplexed 
immunoassay using different antigen labelled barcodes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-24: (a) Schematic of the multiplexed immunoassay using three different 
encoded silica colloidal crystal beads; (b) Reflection image (top) and 
fluorescence microscope image (bottom) of three different encoded silica 
colloidal crystal beads. FITC labelled anti-rabbit IgG was not added and the 
colloidal crystal beads correspond to the rabbit IgG have less or no fluorescent 
signal. Reprinted With permission from (110). Copyright © 2008 American 
Chemical Society. 
 
 
 
1.5. Outline of the Approach to Barcode Generation and Multiplexed Assays Employed 
in this Thesis 
 
This thesis describes the production and application of quantum dot barcodes 
produced by using layer-by-layer assembly of quantum dots onto magnetic bead surface. 
Two types of strategies are used. The first strategy uses thiol chemistry to immobilise 
quantum dots in a layer-by-layer assembly onto magnetic beads. In the second strategy, 
(a) 
(b) 
    
 
 
37 
the interaction between biotin and streptavidin has been exploited to create constructs on 
the bead surface, which can subsequently be read optically.   
 
The streptavidin-biotin interaction is sufficiently strong (Kd≅ 4×10-14 M)(112) that 
the assembled codes are stable over extended periods. The strategy that is proposed in 
this work has a number of advantages over traditional strategies: firstly, the nature of the 
streptavidin-biotin self-assembly provides a reagentless method to bring together modular 
components that may make up the barcode (analogous to biomolecular lego); secondly, 
this assembly process is stable at temperatures above ambient (for example, if the 
barcode were to be used in the polymerase chain reaction, PCR); thirdly the exploitation 
of the streptavidin-biotin conjugation has the potential to enable biological molecules 
subsequently to be bound to the encoded bead (e.g., using biotinylated DNA or antibodies 
to perform encoded ligand binding assays); and finally, importantly, it is well known from 
the microtiter plate industry that streptavidin provides a coating that shows minimal non-
specific binding to proteins, thereby mitigating against significant cross-talk between 
particles, during and after their assembly.  
 
 The experimental work in this thesis can be divided into two parts. The first part 
concerns the layer-by-layer assembly of quantum dots onto the glass substrates to help 
characterise the immobilisation process using for example, X-ray photoelectron 
spectroscopy (XPS) and fluorescence spectroscopy. The second part of the thesis describes 
the production and application of quantum dot barcodes prepared by layer-by-layer 
assembly of quantum dots onto magnetic beads. To show the application of these 
barcodes, multiplexed immunoassays are performed.  
 
The thesis contains six chapters including this chapter. Chapter 2 details materials 
and experimental methods used to carryout the experiments. Chapter 3 details the 
confirmation of immobilisation of quantum dots onto glass substrates using XPS and 
fluorescence spectroscopy. Chapter 4 details the results for the production, 
characterisation and stability of quantum dot barcodes produced by layer-by-layer 
assembly of quantum dot conjugates. Chapter 5 concerns the application of quantum dot 
barcodes for multiplexed immunoassay, and finally Chapter 6 discusses and draws 
conclusions from all the experiments and indicates possible future directions to exploit 
this barcoding technique. 
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Chapter 2 
 
Materials and Methods 
 
 
 
 
 
 
 
  
 This chapter details the materials used in the experimental work for this thesis 
and the different techniques and procedures used to carry out the experiments.  
 
2.1. Layer-by-Layer Assembly of Quantum Dots onto Glass Slides and Magnetic Beads 
using Thiol Chemistry 
  
Quantum dots were immobilised on a plain glass substrate and magnetic beads 
using a thiol-quantum dot linkage,(1) in a layer-by-layer assembly approach. Immobilisation 
on glass substrates was used as a model for characterising interfacial chemistries (e.g. for 
XPS, Chapter 3), whilst that on magnetic beads was ultimately that used in bioassays. The 
materials used for this experiment and detail concerning each method is described below. 
 
2.1.1. Materials 
 
Quantum dots (CdSe/ZnS) dispersed in toluene having emission maximum 
wavelength at 626 nm (QD626) and 555 nm (QD555) were purchased from Evident 
technologies, USA. (3-mercaptopropyl)trimethoxysilane, a dithiol linker 1,9-nonanedithiol, 
cysteamine and toluene were purchased from Sigma-Aldrich. Absolute ethanol was 
  48 
purchased from Fisher Scientific. Plain microscope glass slides, used for the preparation of 
layer-by-layer assembly of quantum dots were purchased from Menzel-Glaser and 
Thermoscientific. Decon 90, a surface active cleaning agent was purchased from Decon 
laboratories limited, UK.  
 
SiMAG-Thiol magnetic beads (1µm diameter) were purchased from Chemicell 
GmbH, Germany. These are aqueous dispersion of non-porous magnetic silica particles that 
are functionalised with thiol (-SH) group. These magnetic silica beads contain iron oxide 
nanoparticles encapsulated inside the beads. The dispersion of these magnetic beads 
contains 9.0×1010 beads/ml of suspension. 
 
2.1.2. Layer-by-Layer Assembly of Quantum Dots onto Glass Slides  
 
 Glass slides were first cut into 1×1 cm2 pieces and cleaned by sonication in 5% 
vol/vol solution of Decon 90 in de-ionised water for 15 min, rinsed with plenty of deionised 
water and dried with nitrogen gas. These glass slides were then modified with 
(3-mercaptopropyl)-trimethoxysilane (MPTS) to introduce thiol groups on the glass 
surface.(2) Briefly, cleaned glass slides were placed in a wide neck round bottom flask 
equipped with a condenser and 400ml isopropyl alcohol (IPA) along with 10ml of water was 
added. To this mixture 10ml of MPTS was added and refluxed for 10 min in the boiling 
silane solution. After this, the flask was removed and allowed to cool. Glass slides were 
then rinsed with IPA and dried with nitrogen gas, Scheme 2-1. The same procedure was 
repeated three times to modify the glass slides. 
  
After modification with MPTS, the glass slides were immediately incubated in 2μM 
solution of quantum dots 626 nm (stock solution of quantum dots was 14.0 μM) in toluene 
for one hour at room temperature. After incubation, these glass slides were rinsed 
exhaustively with toluene and dried with nitrogen gas. For the preparation of multilayers 
of quantum dots, the glass slides were subsequently incubated in a solution of dithiol 
linker(3)as shown in Scheme 2-1.  
 
The glass slides were incubated in 10mM ethanolic solution of 1,9-nonanedithiol 
for one hour. After incubation, the glass slides were rinsed with ethanol and dried with 
nitrogen gas. These slides were then incubated in quantum dots solution (2μM) for one 
hour to make the second layer of quantum dots. 
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Scheme 2-1: Schematic layout of the steps followed for the preparation of 
quantum dots 626 nm (QD626) layer-by-layer assmbly onto the glass substrate. For 
the preparation of mixed multilayers of quantum dots, QD626 and QD555 were 
immobilised in an alternate fashion. Figures are not to scale. 
 
 
 
In this way, by repeating the incubation in 1,9-nonanedithiol and quantum dots 
solutions, multilayers of quantum dots were formed. In these studies ten layers of 
quantum dots were formed on the glass slides using QD626. Two different colour quantum 
dots QD626 and QD555 were also used to make layer-by-layer assembly using the same 
method as described above. These quantum dot multilayers were then characterised using 
X-ray photoelectron spectroscopy and fluorescence spectroscopy.  
 
2.1.3. Immobilisation of Quantum Dots on Thiol (-SH) Modified Magnetic Beads  
 
Thiol modified magnetic silica beads (1µm) were used for making the multilayers 
of quantum dots on the bead surface. By immobilising different quantum dots onto the 
magnetic beads, different fluorescent signatures can be created to produce different 
magnetic bead based barcodes. Magnetic beads were used in order to provide a simple 
technique to separate the beads from the incubartion solution and washing solvent, using 
a magnet (MagnaRack, DNA Research Innovations, UK). The use of magnetic beads made 
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washing with the solvent convenient and efficient than for non-magnetic beads (which 
require centrifugation for separation and washing steps). The magnetic beads also provide 
a means to separate bound and unbound antibodies in later biosensing assays. 
 
Scheme 2-2 shows the layer-by-layer assmbly of different quantum dots onto thiol 
(-SH) modified magnetic beads. Briefly, 2µl of magnetic silica beads (≅1.8 ×108 ) were 
added to an eppendorf tube. To this, 500µl of ethanol was added and, after mixing, beads 
were collected using MagnaRack and ethanol was removed. After this 500µl of ethanol-
toluene (50:50) mixture containing 20µl of QD626 (stock solution 14.0μM) was added and 
incubated for one hour using a vortex mixer at a low speed. Note that ethanol-toluene 
mixture was used because quantum dots are not dispersable in ethanol and the magnetic 
beads were also not well dispersed in toluene. Therefore a mixture of these two solvents 
was used so that both quantum dots and magnetic beads remained well dispersed. After 
one hour, these beads were then separted using MagnaRack to remove excess of quantum 
dots and washed four times to remove any unbound quantum dots using ethanol-toluene 
(50:50) mixture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2-2: Shows the multilayer assembly of QD626 and QD555 using layer-by-
layer assembly onto magnetic bead. A dithiol linker (1,9-nonanedithiol) was used 
to prepare multilayer assemblies. Figures are not to scale. 
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To make a second layer of quantum dots onto the magnetic beads, the magnetic 
beads modified with QD626 were incubated in 500µl of 10mM solution of 1,9-nonanedithiol 
for one hour using the vortex mixer at a low speed. These beads were then washed with 
ethanol to remove excess and unbound dithiol linker. At this step, one thiol group of the 
bifuntional thiol linker was bound to the QD626 and the second thiol group was available for 
binding the next layer of quantum dots. These beads were then incubated with 500µl of 
ethanol-toluene (50:50) mixture containing 5µl of QD555 (stock solution 63.5 μM) quantum 
dots for one hour. After washing to remove unbound quantum dots, magnetic beads were 
redispersed in ethanol. In order to re-disperse the beads in water, these beads were then 
incubated in 10mM solution of cysteamine(1) for one hour. Cysteamine has one thiol (-SH) 
and one (–NH2) functional group. The thiol functional group binds to the quantum dots and 
amino group helps to render the magnetic beads water dispersible. After washing with 
ethanol these barcoded beads were then re-dispersed in deionised water. Single bead 
fluorescence spectroscopy was used to characterise these beads. 
 
2.2. Immobilisation of Quantum Dot Bioconjugates using Layer-by-Layer Biological Self-
Assembly onto Glass Slides and Magnetic Beads 
 
2.2.1. Materials 
 
Plain microscope glass slides used for the preparation of layer-by-layer assembly of 
quantum dots were purchased from Menzel-Glaser and Thermoscientific. Decon 90 was 
purchased from Decon laboratories limited, UK. (3-Aminopropyl)triethoxysilane (APTES), 
biotin, biotinamidohexanoic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt (NHS-
biotin) and biotin-fluorescein were purchased from Sigma-Aldrich, UK. NHS-biotin has an 
aminocaproyl spacer which reduces steric hindrance in binding streptavidin quantum dot 
conjugates. NHS-biotin reacts with primary amines in the pH range 6.5-8.5.   
 
Dynabeads M-280 streptavidin (2.8µm), streptavidin- and biotin-conjugated 
CdSe/ZnS quantum dots (QD605-biotin, QD655-biotin, QD605-streptavidin, QD655-streptavidin, 
QD525-streptavidin, QD565-streptavidin) were purchased from Invitrogen, UK. These 
quantum dot streptavidin or biotin conjugates are semiconductor nanocrystals of CdSe 
around which a semiconductor shell of ZnS is coated to improve the optical properties. 
These core-shell quantum dots are coated with a polymer shell, directly coupled to 
streptavidin or biotin molecules using a polyethylene glycol (PEG)-linker. The size of the 
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quantum dot streptavidin conjugate is ~15-20 nm and that of biotin conjugate is ~10-12 
nm. The loading of streptavidin onto the quantum dots is estimated as 5-10 
streptavidin/QD conjugate while in case of biotin conjugate is 5-7 biotin molecules/QD 
conjugate.(4, 5) Another type of streptavidin conjugates (QD655 ITKTM-streptavidin conjugate 
and QD605 ITKTM-streptavidin conjugate) without a PEG-linker was also purchased from 
Invitrogen (Section 2.2.3.1). 10mM phosphate buffer pH 7.4 (adjusted to an ionic strength 
of 25mM using NaCl and containing 0.002% sodium azide and 0.15% BSA) was prepared 
using ultrapure MilliQ water (Ω>18 MΩ.cm). The word “PBS” is used for this buffer without 
0.15% BSA. 
 
2.2.2. Layer-by-Layer Assembly of QD-Streptavidin and QD-Biotin Conjugates onto 
Plain Glass Substrates 
  
The strepatvidin and biotin interaction was used to immobilise quantum dots onto 
planar glass surface and magnetic beads. A layer-by-layer assembly approach was used to 
concentrate the quantum dots on to the substrate surface. The strategy to immobilise 
quantum dots onto the glass substrate is shown in Scheme 2-3. The glass slides were first  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2-3: Schematic representation of immobilisation of QD525-streptavidin 
(S525) conjugate and QD655-biotin conjugate (B655) using layer-by-layer biological 
self-assembly. Figures are not to scale. 
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cleaned by sonication in 5% vol/vol solution of Decon 90 for 15 min and then rinsed 
exhaustively with water and finally dried with nitrogen gas. To form an amino-terminated 
layer on the glass slides (Scheme 2-3), the substrates were immersed in a 3 vol% solution 
of 3-(aminopropyl)triethoxysilane (APTES) in 95% ethanol for 2h and thoroughly rinsed with 
ethanol and dried with nitrogen gas. The samples were further dried in an oven at 120°C 
for half an hour. After this, the samples were incubated in a solution of NHS-Biotin (1 
mg/ml) for two hours. The solution of NHS-Biotin was prepared in 10mM phosphate buffer 
pH 7.4. After incubation in NHS-biotin, samples were rinsed with buffer and incubated in 
0.15 % solution of bovine serum albumin (BSA) for half an hour. This step was used to block 
the non-specific adsorption of quantum dot conjugates. Samples were then incubated in 10 
nM solution of QD525-streptavidin conjugate (S525) or QD655-streptavidin for one hour. After 
washing with buffer, samples were incubated in 10 nM solution of QD655-biotin (B655) 
solution for one hour to make two layers of quantum dots as shown in Scheme 2-3. In this 
way, 2,4,6,8,10 layers of QD-streptavidin and QD-biotin conjugates were prepared. 
 
 
2.2.3. Layer-by-Layer Assembly of QD-Biotin and QD-Streptavidin Conjugates onto 
Magnetic Beads 
 
For making the first layer of QD605-biotin conjugate (B605), 2µl of streptavidin 
coated magnetic beads (●-) (≅1.4×106 beads) from stock solution were added to 300µl 
of 10mM phosphate buffer pH 7.4 containing 0.15% BSA. To this, 2µl of B605 conjugate 
was added from the stock solution (2.2µM) and incubated for one hour, agitated using 
a vortex mixer at a low speed (Scheme 2-4). After one hour, magnetic beads were 
separated from the quantum dot suspension using MagnaRack. The use of magnetic 
beads made it easy to separate the beads from the unreacted reagent using 
MagnaRack. It also made washing steps easier and faster as comapred to the 
separation and washing using centrifugation. The beads were washed four times with 
the same PBS to remove any non-specifically adsorbed B605 conjugate, and then were 
re-suspended in 300µl of PBS buffer containing 0.15% BSA. These beads were named 
●-B605.  
 
In order to deposit an additional layer of quantum dots, 4µl of 
QD655-streptavidin (S655) conjugate (1µM stock) was added to the bead suspension and 
incubated for one hour. After separation, beads were washed four times with PBS  
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Scheme 2-4: Barcode production using biological self-assembly of quantum dot-
biotin and quantum dot-streptavidin conjugates. 
 
 
 
containing 0.15% BSA and re-suspended in 300µl of the same buffer to make the first  
barcode ●-B605S655. To make subsequent layers of quantum dots, magnetic beads 
containing ●–B605S655 were incubated in B605 and QD605-streptavidin (S605) conjugates. 
Scheme2-4 shows how the assembly process was performed illustrating the creation of 
●-B605S655, ●-B605S655(B605S605)1, ●-B605S655(B605S605)2  and to ●–B605S655(B605S605)n. In this 
manner, using the layer-by-layer assembly of streptavidin-biotin, ●-B605S655 , 
●-B605S655(B605S605)1  and ●–B605S655(B605S605)2 barcodes were prepared. The barcodes 
prepared above were then stored at 4°C in PBS conatining 0.15% BSA for further use. 
The use of BSA helps to stbilise the quantum dot conjugates immobiised onto the 
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magnetic beads. These barcodes were characterised using single bead fluorescence 
spectroscopy. 
 
2.2.3.1. Comparison of Quantum Dot Conjugates Prepared with and without using a 
PEG-Linker for the Production of Quantum Dot Barcodes 
 
 As stated, two types of quantum dot streptavidin conjugates were purchased 
from Invitrogen. The QD-streptavidin conjugates described in Section 2.2.1, 2.2.2 and 
2.2.3 were prepared by covalently attaching streptavidin to the amphiphilic coating (a 
polymer coating) on the CdSe/ZnS quantum dots using a PEG-linker as a spacer 
between CdSe/ZnS and streptavidin. The other streptavidin conjugates were QD655 
ITKTM-streptavidin conjugate and QD605 ITKTM-streptavidin conjugate which were also 
purchased from invitrogen. In these latter types of quantum dot-streptavidin 
conjugates, streptavidin is covalently attached to the amphiphilic coating on the 
quantum dots directly without the use of a PEG-linker. The Scheme 2-4 was used to 
prepare the barcodes using these quantum dot conjugates. Two types of barcodes were 
prepared i.e. ●–B605S*655 and ●–B655S*605 where S*655 is QD655 ITKTM-streptavidin conjugate 
and S*605 is QD605 ITKTM-streptavidin conjugate. The fluorescence properties of these 
barcodes were studied using single bead fluorescence spectroscopy and compared with 
the barcodes prepared in Section 2.2.3.   
 
2.3. X-Ray Photoelectron Spectroscopy (XPS) 
 
XPS or electron spectroscopy for chemical analysis (ESCA) was used to confirm 
the immobilisation of CdSe/ZnS quantum dots onto the glass substrate. Figure 2-1 
shows the schematic of different components of XPS set-up and Scienta ESCA 300 
spectrometer used in these experiments. 
 
All the samples for XPS analysis were prepared on ~1×1 cm2 glass slides and stored 
in vacuum desicator before taking measurements. All the XPS spectra were taken using the 
high resolution Scienta ESCA 300 spectrometer at Daresbury laboratories, UK. The Al K α 
radiation is provided with a rotating anode source and is focussed on the samples at a take 
off angle (TOA) of 45° after passing through the monochromators.(6, 7) To study the 
immobilisation of CdSe/ZnS quantum dots on the glass substrates using dithiol chemistry,  
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Figure 2-1: (a) Schematic of an XPS set up shows X-ray source for the production 
of X-rays and detector to measure kinetic energy and number of electrons 
(reproduced from (8)); (b) Photograph of Scienta ESCA 300 used in the current 
experiments. 
 
 
 
in addition to the survey spectra for each sample, C(1s), N(1s), S(2p), Cd(3d) and Zn(2p) 
high resolution XPS spectra were also measured. Similarly for immobilisation of CdSe/ZnS 
quantum dots using biotin-streptvidin interaction, C(1s), N(1s), Cd(3d) and Zn(2p) high 
resolution XPS spectra were measured in addition to the survey scan for each sample. The 
slit width (0.8 mm) and channel resolution (0.05 eV) were kept constant in all the samples. 
All spectra were adjusted for an offset due to the flood gun by assigining 285 eV to the 
main C—H peak in the C(1s) spectrum as a reference.(7) The deconvolution of the S(2p) 
peaks was performed using CaSaXPS software, Casa Software Limited. When deconvoluting 
the S(2p) peaks, different sulphur species are present as doublets. The doublet appears as 
a consequence of the known 2:1 ratio of S(2p1/2) and S(2P3/2) spin orbit states.(9, 10) The 
known binding energy difference between these spin orbit states is 1.18 ev.(9)  These values 
are used as constrained input parameters to the software during the deconvolution of the 
S(2p) peaks. 
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2.4. Fluorescence Spectroscopy Measurements 
 
For fluorescence measurements, a Nikon microscope (Microphot-SA) (NA=0.85, 40× 
objective)  was coupled with a Triax 320 spectrometer (Jobin Yvon) equipped with a 
symphony CCD detector, Figure 2-2. A true colour CoolSnap CCD camera was used to 
acquire optical images. The filter sets used for fluorescence measurements were from 
Nikon, and are listed in Table 2-1. 
 
Figure 2-2 shows the experimental set-up with a variable aperture. When the 
aperture was fully closed, it produces a spot size of ~50µm diameter of excitation light. 
For the measurement of fluorescence signal from the quantum dots immobilised on the 
glass substrates, the aperture was closed and quantum dots were excited using filter set 
UV-2A and spectra were collected using the spectrometer with 0.1s acquisition time. In 
case of each layer assembly n=5 measurements were taken. Where “n“ is the number of 
measurements taken on one sample at different places. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2: Schematic diagram of fluorescence measurement configuration used 
for single bead fluorescence spectroscopy. 
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Table 2-1: Shows the filter set combinations used for the fluorescence 
spectroscopy measurements. 
 
 
 
For single bead fluorescence measurements, a single bead was focussed using the 
true colour CCD camera image in the middle of the 50µm spot of excitation light and 
spectra were measured by using the spectrometer with an acquisition time of 1s.  
 
In this study, fluorescence intensity ratios of different quantum dots in a barcode 
were used to identify different barcodes. For the barcodes ●-B605S655, ●-B605S655(B605S605)1  
●-B605S655(B605S605)2  prepared in Section 2.2.3, after measuring the single bead 
fluorescence spectra of these barcodes, the ratio of QD605 to QD655 fluorescence intensity 
was determined for each barcode at 605 nm and 655 nm, respetively. These fluorescence 
intensity ratios were plotted against the number of counts (number of beads) of the 
barcodes in case of each barcode preparation. 
 
For the detection of fluorescein isothiocyanate (FITC), B-2A filter set with a band 
pass filter (500-550 nm, Omega optical) was used to distinguish between the FITC and non-
FITC labelled barcodes. Fluorescence micrographs were collected using a true colour CCD 
camera. 
 
2.4.1. Measurement of Number of Quantum Dots 
 
The number of quantum dots per bead was calculated from fluorescence emission 
intensities before and after incubation with magnetic beads, using Eq.2-1 and Eq.2-2.(11)  
Filter set Exc.filter (nm) Dichroic mirror (nm) Em. Filter (nm)  
UV-2A 330-380 400 420 long pass 
B-2A 450-490 500 (i) 515 long pass or 
(ii) 500-550 band 
pass (Omega 
optical) 
G-2A 510-560 565 590 long pass 
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Lb = (Io-Ir) /Io ● [Lo]                 Eq. 2-1 
  
Number of quantum dots/bead = (Lb● NA)/n     Eq. 2-2 
 
Where Lb is the concentration of quantum dots bound to the beads, Io and Ir are the 
background corrected fluorescence intensities of quantum dots before and after 
incubation with the bead suspension, respectively. Lo is the intial concentration of 
quantum dots, NA is the Avogadro’s number and n is the number of beads per litre.  
 
2.5. Stability Studies of Quantum Dot Barcodes Preapred using Layer-by-Layer 
Assembly of QD-Biotin and QD-Streptavidin Conjugates onto Magnetic Beads  
 
 The stability studies of quantum dot barcodes prepared in Section 2.2.3 were 
carried out in terms of thermal stability, stability in biotin solution and long term stability 
of the barcodes. The procedure for these studies is detailed below. 
 
2.5.1. Thermal Stability 
 
The information concerning the thermal stability of the barcodes is important for 
their use in different applications involving prolonged storage or applications at higher 
temperatures. For thermal stability studies, barcode ●-B605S655(B605S605)1  was chosen. The 
barcode ●-B605S655(B605S605)1  was prepared as described in Section 2.2.3. First, single bead 
fluorescence spectroscopy was performed to measure the fluorescence intensity ratio of 
the barcoded beads before heat treatment and then these barcoded beads were treated at 
an elevated temperature (95°C) for 15 min in the PBS containing 0.15% BSA. For heat 
treatment, a beaker with de-ionised water was heated to the desired temperature and an 
eppendorf tube containing PBS buffer with 0.15% BSA was immersed in the beaker. At this 
point, the barcoded magnetic beads ●-B605S655(B605S605)1  were added to the PBS buffer 
containing 0.15% BSA and treated for 15 min. After this the eppendorff tube was allowed 
to cool and kept at 4°C before performing the single bead fluorescence measurements and 
measuring the fluorescence intensity ratios.  
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2.5.2. Stability in Biotin Solutions 
 
 The quantum dot barcodes in Section 2.2.3 were prepared using the biotin-
streptavidin interaction of QD-biotin and QD-streptavidin conjugates onto streptavidin 
coated magentic beads using a layer-by-layer assembly approach. Stability studies in a 
biotin solution helps to understand the disassociation behaviour of these assemblies. For 
this purpose barcode ●-B655S605(B605S605)1  was selected. This barcode has inner layer of QD 
665-biotin conjugate and QD605-streptavidin, QD605-biotin and QD605-streptavidin as the outer 
layers. This enable us to study the unwinding of the barcode down to the last layer of the 
barcode using fluorescence intensity ratio (QD605 to QD655) measurements.  
 
After the preparation of the barcoded beads in 300µl PBS buffer with 0.15% BSA, 
they were divided into five equal portions i.e. 60µl in each of five eppendorf tubes. A 
stock solution of 100mM biotin was prepared separately in PBS containing 0.15% BSA. From 
each eppendorf tube, 60µl of buffer was removed after collecting the beads using 
MagnaRack. To these five different samples, an appropriate amount of biotin stock 
solution (100 mM) was added to make 300µl total volume having biotin concentrations of 
0, 1, 10, 50 and 100 mM. The total volume was made upto 300µl using PBS buffer with 0.15 
%BSA. To the sample tube with 0 mM biotin, only 300µl of PBS buffer with 0.15% BSA was 
added. These five different samples were incubated at room temperature for 1400 min. 
The fluorescence intensity ratio (QD605 to QD655) was measured using single bead 
fluorescence spectroscopy for 100 beads for each sample and data was plotted as a 
histogram.  In another experiment, the barcode ●-B655S605(B605S605)1  was incubated for 
different time intervals from 0, 50, 200, 600, 1000, 1400 min in 100mM biotin solution at 
37°C. The fluorescence intensity ratios for all the samples were measured and plotted as a 
histogram (100 bead samples were measured in each case). 
 
2.5.3. Long-Term Stability 
 
 The long-term stability of the barcode is an important parameter which indicates 
the shelf life of the barcodes. For these studies, barcode ●-B605S655(B605S605)1  was chosen. 
After the preparation of this barcode, the sample was divided into three equal portions. 
The first portion was used to measure the fluorescence intensity ratio of this barcode after 
the preparation and the second and third portions were stored at 4°C in PBS buffer 
containing 0.15% BSA for two months and ten months, rerspectively. After two months, 
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fluorescence intensity ratios were measured using single bead fluorescence spectroscopy 
and the data was plotted as a histogram for 100 beads. After 10 months, the third portion 
was taken out and fluorescence intensity ratios were measured using single bead 
fluorescence spectroscopy. 
 
2.6. Application of Quantum Dot Barcodes to Multiplexed Immunoassays 
 
2.6.1. Materials 
 
In addition to the materials used for the preparation of the barcodes described in 
Section 2.2.1, the detail of the materials used for performing multiplexed immunoassays 
is given below. Rabbit IgG, human IgG, mouse IgG and goat IgG were all polyclonal 
antibodies and were of reagent grade, purchased from Sigma-Aldrich, UK. Protein A-biotin, 
protein G-biotin and IgG free bovine serum albumin (BSA) were purchesd from Sigma-
Aldrich, UK. Fluorescein isothiocyanate (FITC) labelled anti-goat IgG whole molecule 
developed in rabbit, anti-mouse IgG (Fab specific), anti-human IgG whole molecule 
developed in goat were purchased from Sigma-Aldrich. FITC-labelled anti-rabbit IgG was 
purchased from Dako, UK.  
 
Three different PBS buffers were used. PBS buffer without BSA, PBS with 0.15% 
BSA and PBS with 2% BSA. Aliquots of all IgGs, anti-IgG-FITC’s, protein A-biotin and protein 
G-biotin were prepared in PBS using flash freezing with liquid nitrogen before being stored 
at –20°C. Before using, aliquots were equilibrated at room temperature. 
 
2.6.2. Multiplexed Immunoassay using FITC-Labelled Anti-IgGs 
 
As described in Section 2.2.1, different barcodes were prepared such that each 
barcode had a streptavidin as an outer layer, available for the binding of any biotinylated 
antibody. These biotin-binding sites can be used to immobilise different IgGs on the barcoded 
beads. In this type of multiplexed immunoassay, an FITC-labelled anti-IgG was used for 
detection. Four different barcodes were prepared to perform multiplexed immunoassay, 
namely, ●-B605S655 , ●-B605S655(B605S605)1 , ●–B605S605  and ●–B605S565. Scheme 2-5 shows the 
immunoassay scheme for a single IgG and for a solution containing four different IgGs. 
Following steps were followed to perform the multiplexed immunoassay. 
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Scheme 2-5: (a) Immunoassay scheme for a single rabbit IgG-anti-rabbit IgG 
pair; (b) Multiplexed immunoassay scheme showing rabbit IgG (red), human 
IgG (blue), mouse IgG (pink) and goat IgG (green) immobilised on barcoded 
beads. A cocktail of four anti-IgGs (rabbit, human, mouse, and goat) labelled 
with FITC (light green) is added to the mixture. Note that false colours are 
used to represent different barcoded beads and figures are not to scale. 
 
 
 
2.6.2.1. Immobilisation of Protein A-Biotin or Protein G-Biotin  
 
Protein A-biotin was immobilised on barcode ●–B605S655 , ●–B605S655(B605S605)1  and 
●-B605S605. Briefly, 50µl (~2.3 × 105 beads ) from a 300µl barcode stock was added to an 
eppendorff tube. The barcoded beads were collected using MagnaRack and PBS buffer was 
discarded. To this, a 150µl aliquot of  protein A-biotin (1mg/ml) was added and incubated for 
45 min. The beads were agitated every 5-10 min using a pipette in order to ensure the mixing 
of barcoded beads in protein A-biotin solution. After this the barcodes were collected using 
MagnaRack and  excess of protein A-biotin was removed. After washing, with the PBS, these 
barcoded beads were redispersed in 100µl PBS. A similar procedure was used for the 
immobilisation of protein G-biotin on the barcode ●–B605S565. 
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2.6.2.2. Immobilisation of Different Immunoglobulins (IgGs) 
 
The barcoded beads ●–B605S655 , ●–B605S655(B605S605)1  and ●–B605S605 with protein A-biotin 
were used for the immobilisation of rabbit IgG, human IgG and mouse IgG, respectively. The 
barcoded beads with protein A-biotin were collected by using MagnaRack and PBS buffer was 
discarded. To the barcoded beads ●–B605S655 , ●–B605S655(B605S605)1  and ●–B605S605, onto which 
protein A-biotin had been immobilised, 300µl of rabbit IgG (1mg/ml), human IgG (1mg/ml) and 
mouse IgG (1mg/ml) were added respectively and incubated for 45 min. These barcoded beads 
were mixed every 5-10 min using a pipette. These barcodes were then washed exhaustively to 
remove excess of IgGs using PBS which contain 2% BSA. The same procedure was followed to 
immobilise goat IgG (1mg/ml) on the barcode ●–B605S565 using protein G-biotin. At this point a 
specific IgG had been bound to each of the different barcodes. 
 
2.6.2.3. Detection of Different IgGs  
 
The barcoded beads containing different IgGs were mixed in an equal proportion and 
collected using MagnaRack. This mixture was then redispersed in 300µl of PBS buffer 
containing 2% BSA. Equal concentration (1.5 mg/ml) of stock solutions of all four FITC-labelled 
anti-IgGs (anti-rabbit IgG-FITC, anti-human IgG-FITC, anti-mouse IgG-FITC and anti-gorat IgG-
FITC) were made. In the first assay, a cocktail (40µl) of four FITC-lablled anti-IgGs (10µl from 
each) was added to this mixture and incubated for 45 min in the dark by using a vortex mixer 
at a low speed. After this the beads were washed exhaustively with PBS containing 2% BSA to 
remove excess of FITC-labelled anti-IgGs. In a second assay, the procedure of the immunoassay 
was the same but anti-mouse IgG-FITC was not added to the cocktail whilst other three FITC-
labelled anti-IgGs (anti-goat IgG , anti-human IgG and anti-rabbit IgG) were added. In a third 
assay, anti-human IgG-FITC was not added to the mixture and other three FITC-labelled anti-
IgGs (anti-goat IgG , anti-mouse IgG and anti-rabbit IgG ) were added. These beads were then 
analysed using single bead fluorescence spectroscopy. 
 
2.7. Binding Inhibition Immunoassay  
 
 In this immunoassay, FITC-labelled anti-human IgG was used as the detection 
antibodies to detect human IgG in solution. To perform this assay barcode ●-B605S655 was 
prepared using the same method as outlined in Section 2.2.1. After the preparation of 
this barcode, the barcoded beads were re-dispersed in 300μl of PBS buffer containing 
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0.15% BSA. The strategy for performing the assay is shown in Scheme 2-6. Following steps 
were followed to perform the immunoassay for human IgG quantification. 
 
2.7.1. Immobilisation of Protein A-biotin 
 
Briefly, 150µl (≅7.0 × 105 beads ) from a 300µl barcode stock was added to an 
eppendorff tube. The barcoded beads were collected using MagnaRack and PBS buffer was 
discarded. To this, a 450µl aliquot of protein A-biotin (1mg/ml) was added and incubated 
for 45 min, Scheme 2-6a. The beads were agitated every 5-10 min using a pipette in order 
to ensure the mixing of barcoded beads in protein A-biotin solution. After this the 
barcodes were collected using MagnaRack and  excess of protein A-biotin was removed. 
After washing with the PBS containing 0.15% BSA, these barcoded beads were redispersed 
in 150µl PBS containing 0.15% BSA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2-6: Binding inhibition immunoassy of human IgG: (a) immobilisation of 
human IgG on the barcode ●-B605S655 using protein A-biotin; (b) Binding inhibition 
immunoassay scheme for human IgG. Different amounts of human IgG were 
added in the presence of fixed amounts of barcoded beads containing 
immobilised human IgG, FITC-labelled anti-human IgG and rat IgG. 
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2.7.2. Immobilisation of Human IgG onto Barcode ●–B605S655 
 
The barcoded beads ●–B605S655  with protein A-biotin were used for the immobilisation 
of human IgG. These beads with protein A-biotin were collected by using MagnaRack and PBS 
buffer was discarded. To the barcoded beads ●–B605S655 containing protein A-biotin, 300µl of 
human IgG (3 mg/ml) was added and incubated for 45 min. These barcoded beads were mixed 
every 5-10 min using a pipette. As before, these barcodes were then washed exhaustively to 
remove excess of IgG using PBS which contain 2% BSA and redispersed in 300µl of the same 
buffer. At this point human IgG had been bound to the barcode ●–B605S655. 
 
 
2.7.3. Optimisation of FITC Labelled Anti-Human IgG  
 
 The barcoded beads (●–B605S655) containing human IgG were incubated with 
different amounts of FITC-labelled anti-human IgG. Briefly, from 300µl of the barcoded 
beads containing human IgG, 40µl (~9.3 × 104 beads) were added in seven different 
eppendorf tubes. In each of the eppendorf tubes, different amounts of FITC labelled anti-
human IgG were added and volume was made upto 200µl using PBS pH 7.4 contiaining 2% 
BSA in each eppendorf. This reaction mixture was incubated for 45 min. After this the 
beads were washed using the same buffer and analysed using single bead fluorescence 
spectroscopy. 
 
2.7.4. Calibration Curve for the Determination of Human IgG in Solution 
 
 After optimisation of FITC-labelled anti-human IgG concentration, binding 
inhibition immunoassay was performed for the quantification of human IgG. The barcoded 
beads (≅9.3×104 in each reaction mixture) were incubated with different concentrations of 
human IgG (0.5, 1, 5, 10, 20, 30 μg/ml) and fixed concentration of anti-human IgG-FITC 
(20μg/ml) and rat IgG (0.5 μg/ml) in the presence of PBS pH 7.4 containing 2% BSA and 
agitated for 45 min using a vortex mixer at a low speed. The beads were then washed 
exhaustively to remove excess of reagents using PBS pH 7.4 containing 2% BSA and re-
dispersed in the same buffer. The beads were then analysed using single bead 
fluorescence spectroscopy.  
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Chapter 3 
 
Layer-by-Layer Assembly of Quantum Dots  
 
 
 
 
 
 
 
 
 
As described earlier in Chapter 1, the aim of work in this thesis is the 
immobilisation of quantum dots using layer-by-layer methodology to make a sequence of 
shells of quantum dots around the magnetic beads to produce a quantum dot encoded 
system. This chapter is concerned with the underpinning studies concerning the 
immobilisation of quantum dots onto solid substrates to characterise two different  
immobilisation strategies. The surfaces are characterised using X-ray photoelectron 
spectroscopy and fluorescence spectroscopy. Two approaches were used to make the 
multilayer assemblies. In the first approach, a dithiol linker was used to make multilayers 
of CdSe/ZnS quantum dots onto a glass substrate and magnetic beads. In the second 
approach,  biotin and streptavidin conjugated CdSe/ZnS quantum dots were used to make 
multilayers of quantum dots onto a glass substrate. The experiments relating to the 
immobilisation of biotin and streptavidin conjugated quantum dots onto the magnetic 
beads is discussed in Chapter 4.  
 
3.1. Layer-by-Layer Assembly of Quantum Dots onto Glass Substrates using a Dithiol 
Linker 
 
Detailed descriptions of the basic Materials and Methods are provided in Section 
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2.1.2. For using a dithiol linker (1,9-nonanedithiol) to perform layer-by-layer assembly of 
quantum dots, the following procedure was adopted. First the glass substrates were 
cleaned by sonication in 5% vol/vol solution of Decon 90. A layer of 
(3-mercaptopropyl)trimethoxysilane (MPTS) was first immobilised on the glass substrate.(1) 
This layer provided thiol (–SH) functional groups for the binding of quantum dots. Next the 
glass slides were incubated into solution of quantum dots to make first layer of quantum 
dots onto the glass substrate. For making multilayers of quantum dots onto the substrate, 
the glass substrate was incubated in an ethanolic solution of 1,9-nonanedithiol. 1,9-
nonanedithiol contains two terminal thiol groups, one at each end. One thiol (-SH) binds to 
the quantum dots onto the glass substrate leaving the second thiol functional group (-SH) 
for subsequent deposition of second layer of quantum dots as illustrated in Scheme 2-1. 
The above steps were repeated to make ten layers of quantum dots onto the glass 
substrate.  
 
3.1.1. X-Ray Photoelectron Spectroscopy (XPS)  
  
 X-ray photoelectron spectroscopy was used to characterise the immobilisation 
of quantum dots onto the glass substrate. The principle of XPS or ESCA is based on the 
following conservation of energy equation, Eq.3-1.   
 
    hν = Eb + Ekin                          Eq. 3-1 
 
“Where hν is quantum energy, Eb the binding energy of the electron in the matter 
and Ekin the kinetic energy of the ejected electrons.”(2) X-ray photoelectron spectroscopy 
involved “the measurement of kinetic energy of the inner or valence electron ejected by 
an incident photon with a known energy hν.”(2) By knowing the values of hν (determined 
by the X-ray source) and Ekin (measured experimentally), Eb which is a characteristic of 
chemical bonds in a compound, can be calculated. Binding energy values are specific for 
different elements and Eb can be used to identify different elements.  
 
Figure 3-1 shows the XPS survey spectra of four different samples. Figure 3-1a 
shows the XPS survey spectrum of MPTS on the glass substrate. The presence of Si(2p), 
Si(2s), C(1s), O(1s) and S(2p) peaks in the spectrum confirmed the immobilisation of MPTS 
on the glass substrate. After the immobilisation of quantum dots onto the MPTS modified 
substrate, in addition to the previous peaks, a new set of peaks relating to Cd(3d), Se(3p), 
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Zn(2p3/2), Zn(2p) appeared in the spectrum (Figure 3-1b) which confirmed the 
immobilisation of CdSe/ZnS quantum dots onto the MPTS modified glass substrate.  
 
In the next step, the dithiol linker was immobilised on the monolayer of quantum 
dots (Figure 3-1c) and the second layer of quantum dots was immobilised on the dithiol 
modified quantum dot monolayer (Figure 3-1d). The ratio of Zn to C for the monolayer of  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-1: Comparison of XPS survey spectra of four different samples: (a) A 
layer of MPTS on glass; (b) Immobilisation of first layer of quantum dots onto 
MPTS modified glass substrate; (c) Immobilisation of dithiol linker on the 
monolayer of quantum dots immobilised by using MPTS; (d) Immobilisation of 
second layer of quantum dots onto dithiol modified substrate.  
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quantum dots is 2.0 and for the two layers of quantum dots it is 2.5, which indicates that 
the number of quantum dots increased after the second layer deposition. Ideally this value 
should be double than the first layer. The lower value may be due to the fact that in case 
of two layers of quantum dots, the photoelectrons generated in the inner layer of quantum 
dots lose their kinetic energy before reaching to the detector (the photoelectron escape 
depth is 5-10nm).(3) 
 
For the attachment of quantum dots with the thiol (-SH) group from MPTS, high 
resolution XPS scans of S(2p) for the above four samples were taken (Figure 3-2). It can be  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2: Comparison of S(2p) high resolution XPS spectra of: (a) A layer of 
MPTS on glass; (b) Immobilisation of first layer of quantum dots onto MPTS 
modified glass substrate; (c) Immobilisation of dithiol linker on the monolayer of 
quantum dots immobilised by using MPTS; (d) Immobilisation of second layer of 
quantum dots onto dithiol modified substrate.  
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seen that two S(2p) peaks appeared (Figure 3-2a). The main peak at 163.6 eV showed the 
presence of sulphur species from MPTS and the small peak at 168.5 eV showed the 
presence of oxidation of thiol (-SH) groups.(4) The deconvolution of these peaks revealed 
the presence of two different species in the form of a pair of doublets at 162.3 eV and 
163.6 eV. Each doublet was assigned after the deconvolution due to the known 2:1 ratio of 
S(2p1/2) and S(2P3/2) spin orbit states and by providing the value of their energy 
difference of 1.18 eV (5) in the software. The doublet at 162.3 eV corresponds to the  
S-H and the doublet at 163.6 eV indicated the presence of (S-S) group.(6)  
 
After the immobilisation of first layer of quantum dots (Figure 3-2b), the 
deconvolution of the S(2p) peaks indicated the presence of a doublet at 161.6 eV that can 
be assigned to the presence of S-Zn bonds (7) in addition to the S-S doublet 163.6 eV and 
oxidised sulphur at 168.5 eV. Similar results have been reported in the case of silver 
deposition to the mercaptosilane layer.(4, 8) After the deposition of dithiol linker on the 
monolayer of quantum dots, the same set of peaks was appeared again with a more 
contribution of S-S doublet as compared to S-Zn indicating the attachment of (-SH) to the 
quantum dots and the presence of free –SH groups (Figure3-2c).  
 
When the second layer of quantum dots was immobilised, the deconvolution of the 
S(2p) peak revealed the same set of doublets with an increased contribution from the S-Zn 
doublet indicating the bonding of the second layer of quantum dots (S-Zn bonds). These 
studies support that the CdSe/ZnS quantum dots immobilised via layer-by-layer assembly.  
 
Further, to confirm the immobilisation of quantum dots due to the presence of 
thiol groups on the glass substrate, a control experiment was carried out where the glass 
substrate, without prior modification using mercaptosilane, was incubated in a solution of 
quantum dots. Figure 3-3 shows the high resolution XPS spectra of Zn(2p) in case of 
monolayer of quantum dots immobilised using MPTS and without using MPTS i.e. adsorption 
only. It can be seen that the signal from physioadsorbed quantum dots is five times smaller 
than when immobilisation is carried out using MPTS. Similar results were found when high 
resolution XPS spectra of Cd(3d) was compared for both samples (Figure 3-4).  
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Figure 3-3: Comparison of Zn(2p) high resolution XPS spectra of quantum dots 
immobilised with or without using MPTS.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-4: Comparison of Cd(3d) high resolution XPS spectra of quantum dots 
immobilised with or without using MPTS.  
 
 
 
3.1.2. Fluorescence Spectroscopy  
 
Thin films of different number of layers of quantum dots were prepared using the 
layer-by-layer assembly of quantum dots using a dithiol linker. Detailed Materials and 
Methods are described in Section 2.1.2. Figure 3-5 shows the fluorescence intensity 
plotted against number of layers of quantum dots. It can be seen that as the number of 
420 415 410 405 400
0
500
1000
1500
2000
2500 Glass + MPTS + Qdots 
Glass + Qdots 
Binding Energy (eV) 
Co
un
ts
 (
-)
 
Cd(3d5/2) 
Cd(3d) 
Cd(3d3/2)
1030 1025 1020 1015
0
5000
10000
15000
20000
25000 Glass + MPTS + Qdots
Glass + Qdots 
Binding Energy (eV) 
Co
un
ts
 (
-)
 
Zn(2p) 
 73 
layers increases the fluorescence intensity also increases. However, the increase in 
fluorescence is not linear after six layers. This may be due to the inner filter effect.(9) This 
effect appears due to the absorption of the incident or excitation light before it reaches 
the point in the sample at which luminescence is observed and/or re-absorption of some of 
the emitted light, resulting in decrease in fluorescence intensity.(9) Also, as the number of 
layers increased, the standard deviation of fluorescence measurements remained low, 
indicating that the quantum dot layer assemblies were uniform over the substrate.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-5: Layer-by-layer assemblies of CdSe/ZnS quantum dots (QD626) onto 
glass substrate: (a) Fluorescence spectra of different layers of quantum dots onto 
the glass substrate; (b) Layer number vs Fluorescence intensity. The data points 
are the mean measurements and the error bars show the standard deviation for 
n=5 measurements in case of each layer assembly. Where “n” represents the 
number of measurements from a single sample in the case of each layer 
assembly. A UV-2A filter set was employed to excite the quantum dots in the UV-
region using a mercury lamp and to collect the fluorescent signal. The UV-2A 
filter set consists of an excitation filter (330-380 nm), a dichroic mirror (cut-off 
wavelength 400 nm) and a 420 nm long-pass emission filter. The accumulation 
time was 0.1s in case of each measurement. 
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As a preliminary investigation prior to the development of barcode assemblies, 
described below, multicolour quantum dot multilayers were prepared using the same 
experimental procedure by immobilising quantum dot 626nm (QD626) and quantum dot 
555nm (QD555) in an alternate fashion (Figure 3-6). Detailed descriptions of the Materials 
and Methods are provided in Section 2.1.2. Note that QD555 was always the upper quantum 
dot layer in these assemblies and two layers refer to a first QD626 layer and second QD555 
layer. Fluorescence emission spectra of these multilayers showed that signal from both 
types of quantum dots were increased as the number of layers increases. However, the 
increase in fluorescence is not linear in case of QD555. This may be due to the inner filter 
effect as explained earlier. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-6: Layer-by-layer assemblies of QD626 and QD555 onto glass substrates: 
(a) Fluorescence spectra of different layers of quantum dots onto the glass 
substrate. Note that QD555 is the outer layer in all the layer assemblies; (b) Layer 
number vs Fluorescence intensity. The data points are the mean measurements 
and the error bars show the standard deviation for n=5 measurements in case of 
each layer assembly. Where “n” represents the number of measurements from a 
single sample in the case of each layer assembly. A UV-2A filter set was 
employed to excite the quantum dots in the UV-region using a mercury lamp and 
to collect the fluorescent signal. The UV-2A filter set consists of an excitation 
filter (330-380 nm), a dichroic mirror (cut-off wavelength 400 nm) and a 420 nm 
long-pass emission filter. The accumulation time was 0.1s in case of each 
measurement. 
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3.2. Production of Quantum Dot Barcodes using a Dithiol Linker Via Layer-by-Layer 
Assembly onto Magnetic Beads 
 
The above studies showed that mixed quantum dot layers can be assembled onto 
the glass slides. For the preparation of the barcodes onto magnetic beads, thiol (-SH) 
modified magnetic beads (1.0 µm)(●–) were used. Detailed descriptions of the Materials 
and Methods are provided in Section 2.1.3. The beads (●–) were incubated in a solution of 
quantum dot 626nm (QD626) to make the first layer of quantum dots onto the magnetic 
bead surface (●–QD626). To make a second layer of quantum dots these beads were then 
incubated in a solution of dithiol linker to introduce thiol groups on the bead surface so 
that the second layer of quantum dots could be attached to the bead surface. After the 
immobilisation of dithiol linker the beads were then incubated in quantum dot 555nm 
(QD555) solution. After exhaustive washing, the beads (●-QD626QD555) were then incubated 
in 10 mM solution of cysteamine to introduce amine (-NH2) groups on the bead surface in 
order to render them dispersible in water. This procedure was also used to render the 
completed barcode magnetic beads water dispersible. Two types of barcodes were 
prepared (●–QD626) and (●–QD626QD555). The barcode (●-QD626) has only one layer of 
quantum dots and the barcode (●–QD626QD555) has two layers of quantum dots. In case of 
barcode (●–QD626QD555), the first layer is QD626 and the second or outer layer is QD555. After 
the preparation, these barcodes were characterised using single bead fluorescence 
spectroscopy.  
 
Figure 3-7 shows the fluorescence emission spectra of barcode (●–QD626) and 
(●-QD626QD555). It can be seen that the barcode with a single colour (●–QD626) can be 
recognised, however, a barcode with two layers of quantum dots did not give the 
fluorescence signal as expected. The signal related to QD626, which is the underlying layer 
in this barcode did not appear in the spectrum. We hypothesised that this may be due to 
either the presence of the outer layer, which either quenches the inner layer signal and 
only the outer layer signal appeared or it may be due to the inner filter effect.(9)  
 
To investigate this observation further, the barcoded beads (●–QD626QD555) were 
excited with two different excitation wavelengths. In addition to the excitation with a UV-
2A filter set (UV excitation filter 330-380nm with a long pass emission filter 420nm), these 
beads were also excited with a G-2A filter set (green excitation filter 510-560 nm with a 
long pass emission filter 590nm). It can be seen (Figure 3-8) that the signal related to  
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Figure 3-7: Single bead fluorescence spectra of barcode ●–QD626 (left) and 
barcode ●-QD626 QD555 (right). A weak QD626 signal appeared in the barcode 
●-QD626QD555. A UV-2A filter set was employed to excite the quantum dot 
encoded beads in the UV-region using a mercury lamp and to collect the 
fluorescent signal. The UV-2A filter set consists of an excitation filter (330-380 
nm), a dichroic mirror (cut-off wavelength 400 nm) and a 420 nm long-pass 
emission filter. The accumulation time was 1s in case of each measurement. 
 
 
 
QD626 appeared when excited with a green excitation filter (510-560 nm).  Figure 3-8 
shows the fluorescence micrographs of the barcode (●–QD626QD555) when excited using UV-
2A and G-2A filter sets. This confirms that the QD555 outer layer becomes transparent when 
excited at 510-560nm and which results in the fluorescent signal of QD626. These results 
also support our hypothesis that the disappearance of inner layer QD626 signal was due to 
the inner filter effect.  
 
This indicated that in order to make the barcode using multilayers of quantum 
dots, a spacer should be used to separate the quantum dot layers allowing emitted light 
from the inner layer to emerge. Wang et al.,(10) used a silica layer to create a spacing 
greater than 10nm between neighbouring quantum dot layers on magnetic nanoparticles to 
produce different colour barcodes. The silica layer prevents different layer quantum dots 
from interacting with each other so that each quantum dot layer can be efficiently 
excited.  
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Figure 3-8: (a) Single bead fluorescence spectra (left) and fluorescence 
micrograph (right) of barcode ●–QD626QD555. A UV-2A filter set was used for 
excitation of quantum dots encoded bead in the UV-region using a mercury lamp 
and to collect the fluorescent signal or fluorescence micrograph. The UV-2A filter 
set consists of an excitation filter (330-380 nm), a dichroic mirror (cut-off 
wavelength 400 nm) and a 420 nm long-pass emission filter. The accumulation 
time was 1s. (b) Single bead fluorescence spectra (left) and fluorescence 
micrograph (right) of the same bead barcode ●-QD626QD555. A G-2A filter set was 
employed for excitation of quantum dots in the green-region using a mercury 
lamp and to collect the fluorescent signal or fluorescence micrograph. The G-2A 
filter set consists of an excitation filter (510-560 nm), a dichroic mirror (cut-off 
wavelength 565 nm) and a 590 nm long-pass emission filter. The accumulation 
time was 1s. The scale bar is 5µm. 
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3.3. Layer-by-Layer Assembly of Quantum Dot-Biotin and Quantum Dot-Streptavidin 
Conjugates onto Glass Substrates 
 
In order to overcome the problem stated above, quantum dot-streptavidin and 
quantum dot-biotin conjugates were investigated as a means to produce the barcodes with 
suitably separated quantum dot layers. These biomolecules conjugated to the quantum 
dots can provide sufficient spacing to produce quantum dot barcodes. First of all these 
bioconjugates were immobilised on the glass substrate using layer-by-layer assembly of 
biotin-streptavidin interaction and characterised using X-ray photoelectron spectroscopy 
and fluorescence spectroscopy. The detailed procedure for the immobilisation has been 
described in the Materials and Methods Section 2.2.2. 
 
 
3.3.1. X-Ray Photoelectron Spectroscopy (XPS) 
 
X-ray photoelectron spectroscopy (XPS) was used to characterise the 
immobilisation of streptavidin and biotin quantum dot conjugates onto the glass surface. 
Glass substrates were cleaned and 3-aminopropyltriethoxysilane was immobilised on the 
glass surface. Figure 3-9A(a) shows N(1s) high resolution XPS spectrum of aminosilane on 
the glass substrate. The N(1s) spectrum confirmed the presence of two different nitrogen 
species occurring at (399.5 eV and 401.3 eV) two different binding energies separated by 
1.8 ~ 2 eV.(11) This confirms the immobilisation of aminosilane on the glass substrate. The 
component at lower binding energy can be assigned to free aliphatic amino groups and 
component at higher binding energy can be assigned to the protonated aliphatic amino 
groups.(11) 
 
For the immobilisation of streptavidin conjugated quantum dots, glass slides were 
incubated in a solution of 1 mg/ml biotinamidohexanoic acid 3-sulfo-N-hydroxysuccinimide 
ester (NHS-Biotin) in the PBS at pH 8.0 for one hour at room temperature. Figure 3-9A 
shows the N(1s) and C(1s) spectra before (a) and after (b) immobilisation of biotin onto 
the aminosilane modified glass slides. Before immobilisation, the deconvolution of C(1s) 
spectrum shows the presence of two types of carbon species (C-C and C-N). After the 
immobilisation of biotin, one additional peak appeared at 288 eV which corresponded to 
the C=O group from biotin and confirmed the attachment of biotin on the glass 
substrate.(12, 13)  
) 
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To immobilise streptavidin conjugated quantum dots, samples were then 
incubated in a streptavidin conjugated quantum dot (S525) solution in PBS pH 7.4 containing 
0.15 % BSA for 1h to block non-specific adsorption of quantum dot conjugates. These 
substrates were then washed with quantum dot free PBS pH 7.4 containing 0.15% BSA. 
After the immobilisation of streptavidin conjugated quantum dots, the substrate was 
incubated in a biotin conjugated quantum dot (B655) solution for 1h. The sample was then 
washed exhaustively to remove any unbound biotin-quantum dots. A control sample was 
prepared by the incubation of aminosilane modified glass substrate in PBS pH 7.4 
containing 0.15% BSA for half an hour and then it was incubated in streptavidin conjugated 
quantum dot solution for 1h. After washing, the samples were dried under nitrogen gas.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-9: (A) N(1s) high resolution XPS spectra of aminosilane film on the glass 
substrate (a) before and (b) after the immobilisation of NHS-biotin; (B) C(1s) high 
resolution XPS spectra (a) before and (b) after immobilisation of NHS-biotin.  
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Figure 3-10 shows the survey spectra of four different samples prepared for the 
immobilisation of quantum dots using streptavidin and biotin conjugates. The survey scan 
for the glass substrate containing aminosilane and NHS-biotin shows the presence of Si(2p), 
Si(1s), S(2p), C(1s), N(1s) and O(1s) elements. After the immobilisation of streptavidin 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-10: Comparison of XPS survey spectra of four different samples: (a) 
Immobilisation of biotin onto aminosilane modified glass substrate; (b) 
Immobilisation of first layer of streptavidin quantum dot conjugate (S525) using 
biotin-streptavidin interaction; (c) Immobilisation of second layer of quantum 
dots using biotin conjugated quantum dots (B655); (d) A control sample where the 
glass slides containing aminosilane were first incubated in BSA for half an hour 
and then incubated in streptavidin conjugated quantum dots.   
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conjugated and biotin conjugated quantum dots, two additional peaks related to 
Cd(3d5/2), Cd(3d) and Cd(3d3/2) appeared around 405.5 eV and 412.5 eV which confirmed 
the immobilisation of quantum dots. Also a weak signal related to Zn(2p) was found around 
1022 eV.  
 
The presence of these elements indicates that the streptavidin and biotin 
conjugated quantum dots were immobilised on the glass substrate using the layer-by-layer 
assembly. The ratio of N(1s) to Cd(3d5/2) for two layers (streptavidin quantum dots and 
biotin quantum dots) was found to be 2.55 which is higher than the value for the first layer 
(streptavidin quantum dots) 1.75. The ratio values are higher in case of two layers of 
quantum dot conjugates as compared to the monolayer of quantum dot conjugates. This is 
due to the fact that the number of quantum dots immobilised in the case of two layers is 
greater than the monolayer of quantum dots. This also confirms the immobilisation of 
biotin conjugated quantum dots (second layer) onto the streptavidin conjugated quantum 
dots (monolayer) in a layer-by-layer assembly. 
 
In order to confirm that the immobilisation of quantum dot conjugates is via 
biotin-streptavidin interaction, high resolution XPS spectra of Cd(3d) and Zn(2p) were 
measured for the first layer and a control sample (Figure 3-11). A control sample was 
prepared by first incubating aminosilane functionalised glass substrate in PBS pH 7.4 
containing 0.15% BSA for half an hour and then incubated in 10nM solution of QD525-
streptavidin (S525) for 1h. Figure 3-11 shows that streptavidin quantum dot conjugates 
were not immobilised on the control sample confirming that the immobilisation of 
quantum dot conjugates was via biotin-streptavidin interaction rather than the adsorption 
of quantum dot conjugates. Multilayers of quantum dot conjugates can be formed on the 
glass substrate using this layer-by-layer assembly. 
 
3.3.2. Fluorescence Spectroscopy  
 
Optical properties of thin films of quantum dot streptavidin and quantum dot 
biotin conjugates were also studied using fluorescence spectroscopy. In the first 
experiment, ten layers of quantum dot-streptavidin 655 nm (S655) and quantum dot-biotin 
655 nm (B655) were prepared using layer-by-layer biological self-assembly of these 
conjugates on the glass substrate. Figure 3-12 shows the fluorescence spectra of these 
thin films up to ten layers. It can be seen that the fluorescence intensity increased with 
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Figure 3-11: (a) Comparison of Cd(3d) high resolution XPS spectra of quantum 
dots immobilised with or without using biotin-streptavidin interaction; (b) 
Comparison of Zn(2p) high resolution XPS spectra of quantum dots immobilised 
with or without using biotin-streptavidin interaction. 
 
 
 
the increase in number of layers of quantum dot conjugates. Also, and in contrast to 
studies involving quantum dots alone, Figure 3-5 indicates that as the number of layers 
increases the standard deviation also increased.  
 
Similarly, multicolour multilayers of quantum dot-streptavidin 525 nm (S525) and 
quantum dot-biotin 655 nm (B655) conjugates were prepared. Figure 3-13 shows that the 
fluorescence intensity of both the quantum dots increases with the increase in number of 
layers. However, the fluorescence intensity of B655 is higher than the S525 quantum dots. 
Again in these multilayer quantum dot assemblies, the standard deviation is higher than 
the multicolour multilayers of quantum dots produced using a dithiol linker (Figure 3-6).  
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Figure 3-12: Layer-by-layer assemblies of quantum dot-streptavidin 655 nm (S655) 
and quantum-dot biotin 655 nm (B655) conjugates onto glass substrate: (a) 
Fluorescence spectra of different layers of quantum dots onto the glass 
substrate; (b) Layer number vs Fuorescence intensity. The data points are the 
mean measurements and the error bars show the standard deviation for n=5 
measurements in case of each layer assembly. Where “n” represents the number 
of measurements from a single sample in the case of each layer assembly. A UV-
2A filter set was employed to excite the quantum dots in the UV-region using a 
mercury lamp and to collect the fluorescent signal. The UV-2A filter set consists 
of an excitation filter (330-380 nm), a dichroic mirror (cut-off wavelength 400 
nm) and a 420 nm long-pass emission filter. The accumulation time was 0.1s in 
case of each measurement. 
 
 
 
This increase in standard deviation of fluorescence measurements may be due to 
the fact that streptavidin or biotin conjugates have 5-10 or 5-7 streptavidin or biotin 
molecules on each conjugate, respectively and this number varies from conjugate to 
conjugate. Therefore the streptavidin and biotin conjugate thin films are not as compact 
as the thin films of quantum dots formed using a dithiol linker, resulting in a higher 
standard deviation of measurements on different preparations. 
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Figure 3-13: Layer-by-layer assemblies of quantum dot-streptavidin 525 nm (S525) 
and quantum-dot biotin 655 nm (B655) conjugates onto glass substrate; (a) 
Fluorescence spectra of different layers of quantum dots onto the glass 
substrate; (b) Layer number vs Fluorescence intensity. The data points are the 
mean measurements and the error bars show the standard deviation for n=5 
measurements in case of each layer assembly. Where “n” represents the number 
of measurements from a single sample in the case of each layer assembly. A UV-
2A filter set was used to excite the quantum dots in the UV-region using a 
mercury lamp and to collect the fluorescent signal. The UV-2A filter set consists 
of an excitation filter (330-380 nm), a dichroic mirror (cut-off wavelength 400 
nm) and a 420 nm long-pass emission filter. The accumulation time was 0.1s in 
case of each measurement. 
 
 
 
Despite the fact that the standard deviation for these quantum dot assemblies is 
higher, the XPS and fluorescence measurements of these multilayer assemblies indicate 
that the streptavidin and biotin conjugates of quantum dots can be used to produce 
multilayers of quantum dots onto magnetic beads. The production of quantum dot 
barcodes using quantum dot streptavidin and quantum dot biotin conjugates onto the 
magnetic beads is presented in Chapter 4. 
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Chapter 4 
 
Production, Characterisation and Stability of 
Quantum Dot Barcodes 
 
 
 
 
 
  
 This Chapter discusses the assembly process, charcterisation and stability of 
quantum dot barcodes produced by layer-by-layer assembly of streptavidin and biotin 
functionalised quantum dots, based upon biological self-assembly. The strong 
interaction between streptavidin and biotin is exploited to create constructs on the 
bead surface which can subsequently be read optically. The streptavidin-biotin 
interaction is sufficiently strong (Kd ~ 4×10-14 M) that the assembled codes are stable 
over extended periods.(1-5)  
  
4.1. Production of Quantum Dot Barcodes 
 
  Quantum dot barcodes were prepared by sequential assembly of layers of 
biotin and streptavidin conjugated CdSe/ZnS quantum dots onto streptavidin coated 
magnetic beads as described in detail in Section 2.2.3. The streptavidin coated 
magnetic beads (~2.8µm) were first incubated with a suspension of biotin conjugated 
quantum dots (QD605-biotin) in 10 mM PBS buffer, pH 7.4, containing bovine serum 
albumin, BSA, (0.15% w/v), the latter acting to block any free sites for adventitious 
absorption. After incubation, the beads were washed exhaustively with the same  
buffer before a second incubation in a suspension of streptavidin conjugated quantum 
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dots (QD655-streptavidin). Again, after exhaustive washing, the beads were re-
suspended in the same PBS. The use of magnetic beads enabled the rapid manipulation 
of the beads providing a convenient method to wash and separate them after the 
assembly of the sequential layers.(6-8) Using fluorescence microscopy, it was observed 
that the barcodes remained well dispersed in this supporting buffer, and there was no 
evidence of bead clustering, prior to the application of a magnetic field. After 
application of the magnetic field, when the beads were released, again there was no 
evidence of clustering.  
 
 The barcode construct, described above, was given the nomenclature ●–B605S655 
as it comprised a first layer of QD605-biotin (B605), with a second layer of 
QD655-streptavidin (S655) assembled onto magnetic bead (●–). This assembly provided 
free outer streptavidin binding sites that have potential for subsequent assembly of 
biotinylated reagents, including quantum dot-biotin conjugates (e.g. QD605-biotin), or 
affinity ligands. By using this assembly process in conjunction with the large numbers 
of commercially available quantum dots, having well defined surface chemistries there 
is the potential to create a large number of constructs as shown in Scheme 2-4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2-4: Barcode production using biological self-assembly of quantum 
dot-biotin and quantum dot-streptavidin conjugates. Copyright Wiley-VCH 
verlag GmbH & Co. KGaA. Reproduced with permission 
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4.2. Characterisation of Quantum Dot Barcodes 
  
To confirm the formation of barcodes and to investigate the coding potential of 
the layer-by-layer assembly approach, single bead fluorescence spectroscopy was used to 
characterise the different bead assemblies, Figure 2-2. In order to discriminate between 
different barcodes, ratiometric measurements were used rather than measuring the 
absolute intensities of the quantum dots. The ratiometric measurement method has 
previously been proved to be well suited for barcode studies.(9-13) The error in decoding of 
the barcodes is greater in case of using measurement of absolute intensities as a criteria 
for identifying different barcodes, than the ratiometric measurements(9) due to the 
experimental and environmental factors. For example, in the current studies, it is difficult 
to control number of biotin binding sites on the magnetic beads and these varied from 
bead to bead. Similarly, there may be a variation in the size of the bead leading to 
different absolute number of binding sites. The ratiometric measurements reduces the 
error by normalising these factors, and by mitigating against other experimental or 
environmental variations. The method for performing single bead fluorescence 
spectroscopy is described in detail in Section 2.4. 
 
As a proof of principle, to assemble multiple constructs, two different colour 
quantum dots conjugated to either biotin or streptavidin; QD605-biotin, 
QD605-streptavidin and QD655-streptavidin were used. Figure 4-1a shows the spectral 
response of three different barcode constructs ●–B605S655 , ●–B605S655(B605S605)1  and 
●-B605S655(B605S605)2. Figure 4-1b shows the statistical distribution of 605 nm/655 nm 
ratiometric measurements of these three simplest barcode preparations, where the ratios 
of the relative fluorescence intensities are plotted as a histogram, each for 200 beads.  
 
Figure 4-1b shows that the median values for three different barcodes are 
0.94, 1.4 and 1.9 which are different from the expected ratio values of 1, 3 and 5 
considering the number of layers of QD605 and QD655 quantum dots in three different 
barcodes. Moreover, as the number of biologically assembled layers increases, the 
relative standard deviation of the ratiometric measurement also increases. This may 
be due to the variation in the number of quantum dots on a given layer and also as a 
consequence of bead-bead variations in the number of quantum dots bound (It can be 
estimated that there are ~5-10 streptavidin or 5-7 biotin molecules per quantum dot).  
 
  90 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1: Characterisation of barcodes prepared by layer-by-layer assembly of 
QD605-biotin, QD605-streptavidin and QD655-streptavidin: (a) A typical single bead 
fluorescence spectrum measured for ●–B605S655 , ●-B605S655(B605S605)1 and 
●-B605S655(B605S605)2 barcodes (in red, green and blue, respectively). A UV-2A 
filter set was employed to excite the quantum dot encoded beads in the UV-
region using a mercury lamp and to collect the fluorescent signal. The UV-2A 
filter set consists of an excitation filter (330-380 nm), a dichroic mirror (cut-off 
wavelength 400 nm) and a 420 nm long-pass emission filter. The accumulation 
time was 1s for each single bead spectra; (b) Statistical distribution of barcodes 
calculated from fluorescence intensity ratio of QD605 to QD655 for three different 
barcodes using single bead fluorescence spectroscopy. The graph represents data 
collected from 200 beads for each preparation. For barcode ●–B605S655, the 
median value for this preparation is 0.94 with a relative standard deviation of 
5.92%. For barcodes ●-B605S655(B605S605)1 and ●-B605S655(B605B605)2, the median 
values were 1.4 and 1.9 with relative standard deviations of 7.7% and 8.4% 
respectively. Copyright Wiley-VCH verlag GmbH & Co. KGaA. Reproduced with 
permission. 
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Despite this variation in number of binding sites, the ratiometric intensity 
distribution reported here is comparable to, and in most cases much better than that  
previously reported for quantum dot-encoded beads.(13),(14-16) For example, three 
intensity level quantum dot barcodes prepared using polyelectrolyte multilayers 
exhibit standard deviations of between 20-22%.(13) However, the results show that 
when the difference between the highest and lowest fluorescence intensity ratios of 
adjacent barcodes is at least 0.15, different sequences can be identified, Figure 4-1b. 
 
As one of the control experiments, in order to demonstrate that quantum dot 
assembly occurred via streptavidin–biotin conjugation, streptavidin coated magnetic 
beads were sequentially incubated with first QD605-streptavidin and subsequently 
QD655-streptavidin to prepare ●–S605S655. As expected this construct gave no fluorescent 
signal at 605 nm and 655 nm, as there were no available binding sites on the bead to 
bind either S605 or S655 as shown in Figure 4-2. These results provide clear evidence of 
the lack of non-specific adsorption of streptavidin moities to themselves.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-2: Single bead fluorescence emission spectra of barcode ●–B605S655 
and ●-S605S655 shown in red and blue, respectively. A UV-2A filter set was 
employed to excite the quantum dot encoded beads in the UV-region using a 
mercury lamp and to collect the fluorescent signal. The UV-2A filter set 
consists of an excitation filter (330-380 nm), a dichroic mirror (cut-off 
wavelength 400 nm) and a 420 nm long-pass emission filter. The 
accumulation time was 1s for each single bead spectra. 
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In order to study the batch-to-batch variation in the preparation of barcodes, two 
different batches of barcode ●–B605S655(B605S605)1  were prepared and 605 nm/655 nm 
ratios for both were measured and plotted as a histogram as shown in Figure 4-3. The 
detailed description of Materials and Methods is described in Section 2.2. For two 
different batches, the relative standard deviations were found to be 6.7% and 8.3%. It is 
clear that the batch-to-batch variation is not large. 
 
To quantify the number of quantum dots per bead, assays were performed by 
measuring the relative fluorescence intensities of assemblies on magnetic beads as 
detailed in the experimental Section 2.4.1.(13, 17) For the first layer, ●–B605, the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-3: Batch to batch difference in the preparation of barcodes. Statistical 
distribution of barcodes ●–B605S655(B605S605)1 calculated from fluorescence 
intensity ratio of QD605 to QD655 using single bead fluorescence spectroscopy. The 
graph represents data collected from 100 beads for each preparation. For batch 1 
and batch 2, the median values were 1.42 and 1.37 with standard deviations of 
6.7% and 8.3% respectively. A UV-2A filter set was employed to excite the 
quantum dot encoded beads in the UV-region using a mercury lamp and to collect 
the fluorescent signal. The UV-2A filter set consists of an excitation filter (330-
380 nm), a dichroic mirror (cut-off wavelength 400 nm) and a 420 nm long-pass 
emission filter. The accumulation time was 1s for each single bead spectra. 
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number of quantum dots was estimated to be ~1.8×105 which is in close agreement 
with the ~105 estimated geometrically using a bead size of 2.8µm and a quantum dot 
conjugate size of 15-20 nm. For the subsequent layers, the number of quantum dots 
per layer per bead was measured as between ~104 and ~105.  
 
 It was also found that the nature of the quantum dot conjugate was important for 
the immobilisation of quantum dot conjugates on streptavidin beads. Streptavidin 
quantum dot conjugate having a PEG-linker was found to bind to the magnetic beads 
having biotin binding sites resulted in the immobilisation of quantum dot biotin conjugate. 
On the other hand, streptavidin quantum dot conjugate with no PEG-linker (ITKTM quantum 
dot-streptavidin conjugate, Invitrogen) did not bind to the barcode having biotin binding 
sites. Detailed descriptions of the Materials and Methods are provided in Section 2.2.3.1. 
In the preparation of these quantum dot conjugates, streptavidin was covalently attached 
to the quantum dots without the use of a PEG-linker. Two different wavelength quantum 
dot conjugates (without PEG-linker) were used namely these are QD655 ITKTM-streptavidin 
conjugate (S*655) and QD605ITKTM-streptavidin conjugate (S*605), Figure 4-4.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4-4: (a) Fluorescence spectra after immobilisation of                               
QD655 ITKTM-streptavidin conjugate (S*655) on magnetic bead having QD605-biotin 
conjugate (●-B605); (b) Fluorescence spectra after immobilisation of 
QD605ITKTM-streptavidin conjugate (S*605) on magnetic bead having QD655-biotin 
conjugate (●–B655). A UV-2A filter set was employed to excite the quantum dot 
encoded beads in the UV-region using a mercury lamp and to collect the 
fluorescent signal. The UV-2A filter set consists of an excitation filter (330-380 
nm), a dichroic mirror (cut-off wavelength 400 nm) and a 420 nm long-pass 
emission filter. The accumulation time was 1s for each single bead spectra. 
(a) 
550 600 650 700
0
1000
2000
3000
4000
Wavelength (nm) 
Fl
uo
re
sc
en
ce
  
in
te
ns
it
y 
(a
.u
) 
●–B655S*605 
(b) 
550 600 650 700
0
1000
2000
3000
4000
Wavelength (nm) 
 
●–B605S*655 
 
Fl
uo
re
sc
en
ce
  
in
te
ns
it
y 
(a
.u
) 
  94 
It can be seen that a weak signal was found when ITKTM-streptavidin quantum dot 
conjugates were used. This shows that the binding of streptavidin quantum dot conjugate 
to biotin quantum dot conjugate was strongly dependent on the steric hindrance. It is 
hypothesised that the presence of PEG-linker provides flexibility to the streptavidin 
quantum dot conjugate and assist in binding to the bead surface. 
 
Quantum dot barcodes produced by layer-by-layer assembly of biotin and 
streptavidin quantum dot conjugates have streptavidin binding sites for further binding of 
different biotinylated molecules. In order to confirm the presence of streptavidin binding 
sites on barcoded beads and to demonstrate the application of the barcodes as sensors to 
detect an arbitrary biotinylated molecule, biotin-fluorescein was immobilised on ●-B605S655, 
and subsequently washed with PBS containing 0.15% BSA to make ●–B605S655–fluorescein. 
This barcode was mixed with unlabelled ●–B605S655, and analysed using single bead 
fluorescence spectroscopy. Figure 4-5a shows that both labelled (●–B605S655–fluorescein) 
and un-labelled (●–B605S655) barcodes can be identified. The characteristic spectra of the 
●-B605S655 bead remains unchanged after the binding of biotin-fluorescein (Figure 4-5b), 
showing that the barcode information was intact and independent of the nature of the 
molecule being detected. 
 
Further, to detect ●–B605S655–fluorescein in the presence of a second, multilayer, 
barcode, ●–B605S655–fluorescein was mixed with ●–B605S655(B605S605)1 in PBS and analysed 
using single bead fluorescence spectroscopy. As expected, fluorescein was detected on 
barcode ●-B605S655 (Figure 4-6a and Figure 4-6b) only. Note that in Figure 4-6a one bead 
has weak emission because of low level of 605 nm and 655 nm bleeding through the green 
band pass filter. In the absence of green band pass filter, the barcode ●–B605S655 appears 
with a weak emission because it has two layers of quantum dots i.e., QD605 and QD655, 
whilst the barcode ●-B605S655(B605S605)1, which appears brighter, has four layers of quantum 
dots i.e., three QD605 and one QD655. Importantly, Figure 4-5b and Figure 4-6b also show 
the presence of fluorescein on barcode ●–B605S655 through a significant shoulder peak in the 
spectrum at ~530 nm. Figure 4-6b also shows that different barcodes can still be 
identified using the ratio of 605 nm/655 nm fluorescence emission intensity in the 
presence of an additional conjugated molecule. It is clear that both of these barcodes can 
be identified, proving the concept for a range of biological assays to be developed in 
future. 
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Figure 4-5: (a) Fluorescence micrographs of barcode ●–B605S655 and ●–B605S655-
fluorescein beads in the absence (top) and presence (bottom) of green band pass 
filter (500 nm-550 nm). The micrographs show the presence of both fluorescein 
labelled and un-labelled barcodes. Micrographs also show that beads are not cross 
linked and show no tendency to cluster; (b) Single bead fluorescence emission 
spectra of barcode ●–B605S655 and ●-B605S655-fluorescein. Note that after assembly 
of biotin-fluorescein to ●–B605S655, there is a shoulder at ~530 nm whilst there is 
no change in fluorescence of quantum dots. For fluorescence spectra, A B-2A 
filter set was employed to excite the quantum dots and fluorescein encoded 
beads in the blue-region using a mercury lamp and to collect the fluorescent 
signal. The B-2A filter set consists of an excitation filter (450-490 nm), a dichroic 
mirror (cut-off wavelength 500 nm) and a 515 nm long-pass emission filter. The 
accumulation time was 1s for each single bead spectra. Copyright Wiley-VCH 
verlag GmbH & Co. KGaA. Reproduced with permission. 
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Figure 4-6: (a) Fluorescence microscopy image of barcodes ●–B605S655(B605S605)1 and 
●-B605S655-fluorescein beads in the absence (top) and presence (bottom) of  a green 
band pass filter. Note a vestigial colour is seen for the non fluoresceinated bead in 
the lower micrograph due to bleed-through of the intense 605 nm and 655 nm 
emission from the ●-B605S655(B605S605)1 assemblies; (b) Single bead fluorescence 
emission spectra of barcode ●-B605S655(B605S605)1 and ●–B605S655-fluorescein. Note that 
after assembly of biotin-fluorescein to ●–B605S655, there is a shoulder at ~530 nm 
whilst there is no change in fluorescence of quantum dots. A B-2A filter set was 
employed to excite the quantum dots and fluorescein encoded beads in the blue-
region using a mercury lamp and to collect the fluorescent signal. The B-2A filter set 
consists of an excitation filter (450-490 nm), a dichroic mirror (cut-off wavelength 
500 nm) and a 515 nm long-pass emission filter. The accumulation time was 1s for 
each single bead spectra. Copyright Wiley-VCH verlag GmbH & Co. KGaA. Reproduced 
with permission. 
 
 
4.3. Stability Studies of Quantum Dot Barcodes 
 
 The stability of the barcodes is an important parameter to identify the possible 
applications of a barcode system. This section presents the data about the stability studies 
of quantum dot barcodes produced by using biotin-streptavidin interaction of quantum dot 
conjugates on streptavidin magnetic beads. The parameters that have been studied are 
stability of the barcodes at high temperature, incubation in different concentrations of 
biotin, and the long-term stability of barcodes when stored in PBS pH 7.4 containing 0.15% 
BSA. 
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4.3.1. Thermal Stability 
 
Stability of the barcodes at higher temperatures is important where higher 
temperatures are required in certain applications like PCR. In order to study the stability 
of the barcodes, ●-B605S655(B605S605)1 was treated at an elevated temperature (95°C) for 15 
min in the PBS buffer pH 7.4 containing 0.15% BSA. Detailed descriptions of the Materials 
and Methods are provided in Section 2.5.1.Single bead fluorescence spectra were 
measured and fluorescence intensity ratio (QD605 to QD655) before and after the treatment 
at higher temperature was calculated and plotted as a histogram as shown in Figure 4-7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-7: Heat treatment of barcode ●–B605S655(B605S605)1. Barcoded beads were 
heated and maintained at 95°C for 15 min in PBS containing 0.15% BSA. Single 
bead fluorescence spectra were taken before and after the treatment. The 
statistical distribution of the barcodes was calculated by collating fluorescence 
intensity ratios of QD605 to QD655 for 100 beads, in each case. A UV-2A filter set 
was employed to excite the quantum dot encoded beads in the UV-region using a 
mercury lamp and to collect the fluorescent signal. The UV-2A filter set consists 
of an excitation filter (330-380 nm), a dichroic mirror (cut-off wavelength 400 
nm) and a 420 nm long-pass emission filter. The accumulation time was 1s for 
each single bead spectra. 
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It is clear that the barcode information is intact and no change in the distribution 
of fluorescence emission ratios was observed. Although the fluorescence intensity ratio 
distribution is different after treatment at higher temperature but it lies in the same 
range as before the treatment at higher temperature. This experiment confirms the 
stability of the barcodes prepared by using biotin-streptavidin interaction.  
 
4.3.2. Stability in Biotin Solution 
 
To further assess the stability of the barcodes, ●–B655S605(B605S605)1  was incubated 
in  solutions of different concentrations of biotin.  This barcode has one inner layer of 
QD655 and three outer layers of QD605. The decrease in the fluorescence ratio 
measurements gave information about the disassembly of the barcode produced by layer-
by-layer assembly of QD-biotin and QD-streptavidin conjugates. The barcoded beads were 
incubated in solutions of biotin at concentrations between 1 and 100 mM at room 
temperature (Figure 4-8). Detailed descriptions of the Materials and Methods are provided 
in Section 2.5.2. It can be seen that 1mM biotin has nearly no effect on the barcode 
assembly. Interestingly the barcode did not disassemble completely when exposed to 
100mM biotin, even after 1400 min at room temperature. However, the first two layers of 
QD605-streptavidin and QD605-biotin were disassembled after 1400 min incubation in 10mM, 
50mM and 100mM biotin solutions.   
 
It can be hypothesised that, as the number of layers of biotin and streptavidin 
quantum dot conjugates increases, the compactness of the layers decreases. The first two 
outer layers were disassembled quickly as compared to the inner two layers. Due to the 
compactness of the film for the first two inner layers, biotin molecules could not displace 
the QD-conjugates and more energy is required for biotin molecules to displace QD-
conjugates from the streptavidin bead. 
 
Therefore, in order to see whether this hypothesis was true, ●–B655S605(B605S605)1 
barcode was incubated in 100mM biotin solution at 37ºC for different time intervals 
(Figure 4-9). It is clear from the Figure 4-9 that the disassembly process is slow and 
requires 1400 min for the barcode to disassemble completely after incubation at 37ºC. 
Fluorescence intensity ratio values showed that after 200 min, the two outer layers of the 
barcodes were disassembled as the ratio values are in the range of barcode ●–B655S605 which 
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is two layers less than the barcode ●-B655S605(B605S605)1. After 600 min nearly 20% of the 
beads showed that the barcode completely disassembled while other beads still have 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-8: Statistical distribution of (QD605 to QD655) fluorescence intensity ratio 
of barcode ●–B655S605(B605S605)1 incubated for 1400 min at different concentrations 
of biotin (0-100mM). Data collected from 100 single bead spectra for each 
concentration. A UV-2A filter set was employed to excite the quantum dots in the 
UV-region using a mercury lamp and to collect the fluorescent signal. The UV-2A 
filter set consists of an excitation filter (330-380 nm), a dichroic mirror (cut-off 
wavelength 400 nm) and a 420 nm long-pass emission filter. The accumulation 
time was 1s for each single bead spectra. 
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Figure 4-9: (a) Statistical distribution of QD605 to QD655 fluorescence intensity ratio of barcode 
●–B655S605(B605S605)1 incubated in 100mM biotin solution at 37ºC for different time intervals. Data 
collected from 100 single bead spectra for each time interval; (b) The decrease in 
fluorescence intensity ratio is plotted against time by using data from a. The error bars show 
standard deviation from data collected for 100 beads at each time interval; and (c) 
Corresponding fluorescence emission spectra of the barcode ●–B655S605(B605S605)1 at different 
time intervals after incubation in 100mM biotin solution at 37ºC. A UV-2A filter set was 
employed to excite the quantum dot encoded beads in the UV-region using a mercury lamp 
and to collect the fluorescent signal. The UV-2A filter set consists of an excitation filter (330-
380 nm), a dichroic mirror (cut-off wavelength 400 nm) and a 420 nm long-pass emission 
filter. The accumulation time was 1s for each single bead spectra. 
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remaining two layers of quantum dot conjugates. Notably at 1000 min, the ratio values 
again increased due to the disassembly of both B655 and S605 layers at nearly equal rates 
and in addition, the overall fluorescence intensity decreased. Also the number of beads 
with no quantum dots has also increased. This disassembly process also supports the 
hypothesis that the barcodes were produced by the layer-by-layer assembly of quantum 
dot conjugates. 
 
4.3.3. Long-Term Stability 
 
An important indicator of the stability of barcodes is the long-term stability. The 
stability of the barcode was studied by measuring the fluorescence intensity ratio of 
barcode ●-B605S655(B605S605)1 after 2 months and 10 months. Detailed descriptions of the 
Materials and Methods are provided in Section 2.5.3. The fluorescence intensity ratio of 
QD605 to QD655 of barcode ●–B605S655(B605S605)1 when it was prepared and after 2 months was 
plotted as a histogram for comparison (Figure 4-10).  
 
It can be seen that the barcode fluorescence intensity ratio was changed slightly 
after storage in PBS containing 0.15% BSA for 2 months at 4°C. However, this change did 
not affect the identification of the barcode. On the other hand, in case of 10 months 
storage, the barcode disassembled completely giving no fluorescence. This may be due to 
the instability of the quantum dot-conjugates after long-term storage and quantum dot 
conjugates were no longer attached to the bead surface.  
 
To assess this assumption and to find out whether streptavidin beads retain 
streptavidin-binding sites, these beads were incubated again with QD605-biotin and 
QD655-strepatvidin to prepare ●-B605S655. It can be seen that the barcode can be prepared 
by re-using the streptavidin beads as shown in Figure 4-10b which support the fact that 
the quantum dot conjugates were unstable and disassembled from the bead surface 
leaving the streptavidin beads with no fluorescence. Although the fluorescence signal can 
be obtained for barcode ●–B605S655 not all the beads gave the same fluorescence signal. 
This is because the streptavidin beads were already coated with the biotin, therefore 
there were fewer of biotin binding sites remain on these beads and this number of binding 
sites varied greatly from bead to bead as compared to the fresh streptavidin beads used to 
prepare the barcode.  
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Figure 4-10: (a) Long term stability of barcode ●–B605S655(B605S605)1. Single bead 
fluorescence spectra were measured before (red) and after the storage of the 
barcode at 4°C for two months (blue). A UV-2A filter set was employed to excite 
the quantum dots in the UV-region using a mercury lamp and to collect the 
fluorescent signal. The UV-2A filter set consists of an excitation filter (330-380 
nm), a dichroic mirror (cut-off wavelength 400 nm) and a 420 nm long-pass 
emission filter. The accumulation time was 1s for each single bead spectra. The 
statistical distribution of the barcodes was calculated by collating fluorescence 
intensity ratios of QD605 to QD655 for 100 beads, in each case. Barcodes stored for 
10 months gave no fluorescence; (b) Fluorescence emission spectra of barcode ●–
B605S655 prepared by re-using streptavidin beads from the barcodes 
●-B605S655(B605S605)1 which were stored for 10 months.  
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Chapter 5 
 
Applications of Quantum Dot Barcodes in 
Immunoassays 
 
 
 
 
 
 
 
 
 
In recent years, the development of barcoded beads for multiplexed analysis has 
received great attention in analytical biotechnology. The encoded bead (barcode) 
technology has promising applications for multiplexing bioassays and can overcome many 
of the disadvantages in microarray technology. Over recent years different strategies have 
been reported for the preparation of barcodes, which are discussed in detail in Chapter 1. 
Unlike the microarray technology, barcoded beads benefited from different mass transfer 
characteristics giving enhanced solution kinetics when compared with planar diffusion as 
the case of microarray. This Chapter discusses the application of quantum dot barcodes 
produced by layer-by-layer assembly of quantum dot-biotin and quantum dot-streptavidin 
conjugates on a magnetic bead surface for multiplexing immunoassays.  
 
5.1. Application of Quantum Dot Barcodes in Multiplexing Bioanalysis  
 
Quantum dot barcodes prepared by layer-by-layer assembly of quantum dot 
conjugates on magnetic beads (Section 2.2.3) were characterised using single bead 
fluorescence spectroscopy (Section 4.3) and tested for the multiplexed immunoassays. 
Detailed descriptions of the Materials and Methods for performing multiplexed 
immunoassays are provided in Section 2.6. The magnetic bead based barcodes can be 
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identified upon the basis of different spectral responses from different quantum dots 
assembled on the bead surface, using the biological self-assembly of quantum dot 
biotin and quantum dot streptavidin conjugates. The barcode preparation is such that 
each barcode has streptavidin binding sites available for binding of any subsequent 
biotinylated molecule. For performing multiplexed immunoassays, four different IgGs 
namely, rabbit IgG, human IgG, mouse IgG and goat IgG with their corresponding anti-
IgGs labelled with FITC were chosen. Scheme 2-5, shows the immunoassay scheme for 
single IgG and in case of the four different IgGs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2-5: (a) Immunoassay scheme for a single rabbit IgG-anti-rabbit IgG pair; (b) 
Multiplexed immunoassay scheme showing rabbit IgG (red), human IgG (blue), mouse 
IgG (pink) and goat IgG (green) immobilized on barcoded beads. A cocktail of four 
anti-IgGs (rabbit, human, mouse, and goat) labelled with FITC (light green) is added 
to the mixture. Note that false colours are used to represent different barcoded 
beads and figures are not to scale. 
 
 
 
Four different quantum dot barcodes were prepared on the magnetic bead surface 
(●–), namely, ●–B605S655, ●–B605S655(B605S605)1 , ●–B605S605 and ●–B605S565. After the preparation 
of four different barcodes, the fluorescent signal was measured by using single bead 
fluorescence spectroscopy as shown in Figure 5-1.  
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Figure 5-1: Single bead fluorescence spectra of four different barcodes prepared 
using layer-by-layer assembly of quantum dot biotin (QD605-biotin) and quantum 
dot streptavidin (QD-655, QD605 and QD565) conjugates on a streptavidin coated 
magnetic bead (●–). A B-2A filter set was employed to excite the quantum dots in 
the blue-region using a mercury lamp and to collect the fluorescent signal. The B-
2A filter set consists of an excitation filter (450-490 nm), a dichroic mirror (cut-
off wavelength 500 nm) and a 515 nm long-pass emission filter. The accumulation 
time was 1s for each single bead spectra.  
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As can be seen from Figure 5-1, these barcodes can be clearly distinguished from 
each other. As stated, each barcode has streptavidin as an outer protein layer, which can 
be used for the immobilisation of any biotinylated molecule. Therefore for performing 
multiplexed immunoassay, protein A-biotin or protein G-biotin was used to capture 
different IgGs. Protein A and Protein G are bacterial antibody binding proteins which bind 
to the Fc region of the IgGs.1 The binding capacity of these proteins vary with the species 
and subclass of IgG.2 
 
Biotin labelled protein A was immobilised on ●–B605S655, ●–B605S655(B605S605)1 and 
●-B605S605 to capture rabbit IgG, human IgG and mouse IgG, respectively (Scheme 2-5). 
Protein G-biotin was immobilised on ●–B605S565 to capture goat IgG from the solution due to 
its strong binding with goat IgG as compared to protein A.3 Each barcode was washed 
exhaustively with PBS pH 7.4 containing 2% BSA to remove excess IgGs using a magnet to 
separate the beads from the washing solution. After immobilisation, each barcode has a 
specific IgG available for capture of the complementary specific anti-IgG. To measure 
these IgGs immobilised on the barcode surface, FITC labelled anti-IgGs of all four species 
were used. For performing multiplexed immunoassay, appropriate amount of each barcode 
labelled with specific IgG were mixed together. To this mixture, a cocktail of anti-IgGs 
labelled with FITC (anti-rabbit IgG-FITC, anti-human IgG-FITC, anti-mouse IgG-FITC and 
anti-goat IgG-FITC) was added and the measured single bead fluorescence spectra of the 
barcoded beads were as shown in Figure 5-2. 
 
 The fluorescein signal appeared as a shoulder at ~530 nm in each barcode 
spectra confirming the attachment of all four FITC-labelled anti-IgGs to their 
corresponding IgGs, Figure 5-2 and Figure 5-3. 
 
In order to demonstrate the specificity of these IgG-anti-IgG pairs and also to confirm 
whether the signal appeared on each barcode was specific, anti-rabbit, anti-human and anti-
goat FITC-labelled IgGs were added to a mixture of four barcodes, as constructed above (anti-
mouse IgG-FITC was not added to the mixture). A strong FITC signal (shoulder at 530 nm) only 
appeared on three barcodes for which corresponding anti-IgGs-FITC were added, Figure 5-4A.  
The weak FITC signal appeared in the case of barcode ●–B605S605 (pink) which has mouse 
IgG immobilised on its surface. Similarly, in further analogous experiments, anti-human IgG-
FITC was not added to the four bead constructs and a similar outcome was achieved with a 
weak FITC signal generated (namely ●–B605S655 (B605S605)1, blue, Figure 5-4B). 
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Figure 5-2: Single bead fluorescence spectra of four different barcodes measured 
before and after performing multiplexed immunoassay. A B-2A filter set was 
employed to excite the quantum dots and fluorescein in the blue-region using a 
mercury lamp and to collect the fluorescent signal. The B-2A filter set consists of an 
excitation filter (450-490 nm), a dichroic mirror (cut-off wavelength 500 nm) and a 
515 nm long-pass emission filter. The accumulation time was 1s for each single bead 
spectra. Rabbit IgG was immobilised on barcode ●-B605S655 (red), human IgG was 
immobilised on barcode ●–B605S655 (B605S605)1 (blue), mouse IgG was immobilised on 
barcode ●-B605S605 (pink) and goat IgG was immobilised on barcode ●-B605S565 (green). 
All the spectra are on the same scale. 
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Figure 5-3: Multiplexed immunoassay using four different IgGs immobilised on 
four different barcodes. Rabbit IgG was immobilised on barcode ●–B605S655 (red), 
human IgG was immobilised on barcode ●–B605S655 (B605S605)1 (blue), mouse IgG was 
immobilised on barcode ●-B605S605 (pink) and goat IgG was immobilised on barcode 
●–B605S565 (green): (a) Single bead fluorescence spectra of four different IgG 
functionalised barcodes after the addition of a cocktail of four different FITC-
labelled anti-IgGs. A B-2A filter set was employed to excite the quantum dots and 
fluorescein in the blue-region using a mercury lamp and to collect the fluorescent 
signal. The accumulation time was 1s for each single bead spectra;(b) The data 
represent mean fluorescence intensity (n=25 single bead spectra) measured from 
barcoded beads in each case at 530 nm. Where “n” represents number of single 
beads analysed using single bead spectroscopy. 
 
 
 
To determine the origin of this signal and whether it was due to the cross 
reactivity of immunoglobulins or non-specific binding (NSB) of anti-IgGs-FITC on the 
barcode surface, control experiments were performed where FITC labelled anti-IgGs 
were added to the barcode ●–B605S565 without immobilising IgGs on the barcode surface.  
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Figure 5-4: Multiplexed immunoassay using four different IgGs immobilised on four 
different barcodes. Rabbit IgG was immobilised on barcode ●–B605S655 (red), human IgG 
was immobilised on barcode ●–B605S655 (B605S605)1 (blue), mouse IgG was immobilised on 
barcode ●-B605S605 (pink) and goat IgG was immobilised on barcode ●–B605S565 (green): (A) 
Anti-mouse IgG-FITC was not added to the mixture of barcodes. Other three FITC-
labelled anti-IgGs were added; (a) Single bead fluorescence spectra of four different IgG 
functionalised barcodes after the addition of a cocktail of three different FITC-labelled 
anti-IgGs; (b) The data represent mean fluorescence intensity (n=25 single bead spectra) 
measured from barcoded beads in each case at 530 nm; Where “n” represents number 
of single beads analysed using single bead spectroscopy. (B) Anti-human IgG-FITC was 
not added to the mixture of barcodes and three other FITC-labelled anti-IgGs were 
added to the barcode mixture; (a) Single bead fluorescence spectra of four different IgG 
functionalised barcodes after the addition of a cocktail of three different FITC-labelled 
anti-IgGs; (b) The data represent mean fluorescence intensity (n=25 single bead spectra) 
measured from barcoded beads in each case at 530 nm. Where “n” represents number 
of single beads analysed using single bead spectroscopy. A B-2A filter set was employed 
to excite the quantum dots in the blue-region using a mercury lamp and to collect the 
fluorescent signal. The accumulation time was 1s for each single bead spectra. 
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Figure 5-5: Control experiment showing the single bead spectra of the barcode 
●-B605S565 before and after incubation in a cocktail of four different FITC-labelled 
anti-IgGs. The shoulder peak around 530 nm did not appear after incubation of the 
barcode in the FITC-labelled anti-IgGs. Note this is a representative spectra. In this 
control experiment 25 single bead spectra were taken. A B-2A filter set was 
employed to excite the quantum dots in the blue-region using a mercury lamp and to 
collect the fluorescent signal. The B-2A filter set consists of an excitation filter (450-
490 nm), a dichroic mirror (cut-off wavelength 500 nm) and a 515 nm long-pass 
emission filter. The accumulation time was 1s for each single bead spectra. 
 
 
 
No FITC signal was recorded in the barcode spectra (Figure 5-5), confirming that the 
background signal was not due to NSB but instead was probably as a consequence of 
the cross-reactivity of the polyclonal immunoglobulins.4 These findings are consistent 
with the known observation that streptavidin can generate a protein resistant coating 
(evidenced by its established application in functionalising microtitre plate wells for 
conventional immunoassays).  
 
Instead of measuring the spectral response, the immunoassay on the beads could 
be readily visualised using an optical microscope with a green band pass filter (500 nm-550 
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nm) to discriminate between bound and unbound antibodies. Two barcodes were used for 
these experiments, ●–B605S655 and ●-B605S655(B605S605)1 labelled with rabbit IgG and human 
IgG, respectively. To this mixture anti-rabbit IgG-FITC was added and incubated for 45 
min. Note that anti-human IgG-FITC was not added to the mixture. After exhaustive 
washing these beads were imaged in the presence and absence of green band pass filter. 
When a green band pass filter was used, only the barcode ●–B605S655 immobilised with 
rabbit IgG gave a strong FITC signal (confirming the binding of anti-rabbit IgG to rabbit IgG 
immobilised on barcoded ●–B605S655 bead), Figure 5-6. The weak FITC fluorescent signal 
seen on the barcode ●–B605S655(B605S605)1, Figure 5-6, can again be attributed to the cross 
reactivity of anti-rabbit IgG with human IgG as noted in Figure 5-4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-6: Shows fluorescence micrographs of barcodes ●–B605S655 and 
●-B605S655(B605S605)1 containing rabbit IgG and human IgG, respectively after the 
addition of FITC-labelled anti-rabbit IgG in the absence (left) and presence 
(right) of a green band pass filter (500 nm-550 nm). The image at left was taken 
by exciting quantum dots using UV-2A filter. The UV-2A filter set consists of an 
excitation filter (330-380 nm), a dichroic mirror (cut-off wavelength 400 nm) and 
a 420 nm long-pass emission filter. The image at right was taken by excitation of 
quantum dots in the blue region using B-2A filter set containing band pass 
emission filter (500 nm-550 nm) instead of 515 nm long-pass emission filter. 
 
 
 
 
10μm 10μm 
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5.2. Binding Inhibition Immunoassay using Quantum Dot Barcodes 
 
The above experiments in Section 5.1 showed that quantum dot encoded beads 
prepared using quantum dot-biotin and quantum dot-streptavidin conjugates are suitable 
for performing multiplexed immunoassays. The above experiments however showed a 
qualitative measure of the multiplexed immunoassay. This section describes the 
quantitative immunoassay for human IgG to show that these barcodes can also be used to 
perform a quantitative immunoassay (Scheme 2-6). Detailed descriptions of the Materials 
and Methods for performing binding inhibition immunoassay are provided in Section 2.7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2-6: Binding inhibition immunoassy of human IgG: (a) immobilisation 
of human IgG on the barcode ●-B605S655 using protein A-biotin; (b) Binding 
inhibition immunoassay scheme for human IgG. Different amounts of human 
IgG were added in the presence of fixed amounts of barcoded beads containing 
immobilised human IgG, FITC-labelled anti-human IgG and rat IgG. 
 
 
 
Human IgG was used as the analyte and FITC labelled anti-human IgG was used as 
the detection antibody. Also rat IgG was used as a control for non-specific binding. The 
first step involved the determination of the amount of anti-human IgG-FITC that can be 
added for the detection of human IgG. For this purpose, human IgG was immobilised on 
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the barcoded bead (●–B605S655) using protein A-biotin as described in Section 2.7. After this 
the beads were incubated with different concentrations of anti-human IgG-FITC (0.25, 0.5, 
1, 5, 10, 20, 30 μg/ml) in the presence of PBS pH 7.4 containing 2% BSA and agitated for 
45 min using a vortex mixer at a low speed. After exhaustive washing, the barcoded beads 
were analysed using single bead fluorescence spectroscopy and measurement of the FITC 
signal at 530 nm. Fluorescence signals were plotted for different concentrations of anti-
human IgG-FITC, Figure 5-7. It can be seen that above 20μg/ml of anti-human IgG-FITC, 
the FITC signal saturated. The assumption is made that at this concentration, all binding 
sites on the bead are occupied. This concentration of anti-human IgG-FITC was 
subsequently used to perform the binding inhibition immunoassay for human IgG. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-7: Optimisation of FITC labelled anti-human IgG concentration for 
performing binding inhibition immunoassay for human IgG using the barcode 
●-B605S655. The data points are the mean measurements of the fluorescence 
intensity of FITC at 530 nm and the error bars show the standard deviation for 
n=25 measurements. Where “n=25” represents 25 single bead spectra from 25 
beads in case of each reaction mixture. A B-2A filter set was employed to excite 
the quantum dots and fluorescein in the blue-region using a mercury lamp and to 
collect the fluorescent signal. The B-2A filter set consists of an excitation filter 
(450-490 nm), a dichroic mirror (cut-off wavelength 500 nm) and a 515 nm 
long-pass emission filter. The accumulation time was 1s for each single bead 
spectra. 
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After the optimisation of FITC labelled anti-human IgG, immunoassay was 
performed for the determination of human IgG in a mixture of human IgG and rat IgG. In 
order to perform this, human IgG was first immobilised on the barcoded bead (●–B605S655) 
using protein A-biotin as described in Section 2.7. The beads (≅9.3×104 in each reaction 
mixture) were then incubated with different concentrations of human IgG (0.5, 1, 5, 10, 
20, 30 μg/ml) and fixed concentrations of anti-human IgG-FITC (20μg/ml) and rat IgG (0.5 
μg/ml) in the presence of PBS pH 7.4 containing 2% BSA and agitated for 45 min using a 
vortex mixer at a low speed. After exhaustive washing with the same buffer, these beads 
were analysed using single bead fluorescence spectroscopy to measure different 
concentrations of human IgG added to the reaction mixture, Figure 5-8. It can be seen  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-8: Shows the binding inhibition immunoassay using the barcode 
●-B605S655 for the determination of different concentrations of human IgG: (a) 
Fluorescent signal of FITC labelled anti-human IgG decreases with the increase in 
human IgG concentration; (b) An exponential decay curve was obtained by fitting 
the plotted data using exponential decay model. The data points are the mean 
measurements of the fluorescence intensity of FITC at 530 nm and the error bars 
show the standard deviation for n=25 measurements in each case. Where “n=25” 
represents 25 single bead spectra from 25 beads in case of each reaction 
mixture. A B-2A filter set was employed to excite the quantum dots and 
fluorescein in the blue-region using a mercury lamp and to collect the 
fluorescent signal. The B-2A filter set consists of an excitation filter (450-490 
nm), a dichroic mirror (cut-off wavelength 500 nm) and a 515 nm long-pass 
emission filter. The accumulation time was 1s for each single bead spectra. 
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that as the human IgG concentration increases, FITC signal decreases with the increase in 
concentration of human IgG in the reaction mixture. This is due to the fact that free human 
IgG binds with anti-human IgG-FITC resulting in the decrease of anti-human IgG-FITC signal 
on the barcoded bead. These results show that the barcodes prepared by using quantum 
dot-biotin and quantum dot-streptavidin conjugates can be used for the measurement of 
different immunoglobulins. 
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Chapter 6 
 
Summary, Conclusions and Future Prospects 
 
 
 
 
 
 
 
 
 
The experimental work in this thesis employed layer-by-layer assembly of different 
colour quantum dots to prepare encoded magnetic beads. The use of magnetic beads to 
prepare barcodes provides a simple technique to separate the beads from the incubation 
and washing solutions during the course of a biological assay. The magnetic collection 
method associated with the separation and washing of the encoded magnetic beads has 
great advantage over the centrifugation methods required for similar silica or latex bead 
based constructs. This magnetic method provides an easy way to separate bound and 
unbound antibodies in a biosensing assay.  
 
Two approaches were used to prepare quantum dot encoded magnetic beads. The 
first approach was based on making layer-by-layer assembly of CdSe/ZnS quantum dots 
onto the magnetic beads using thiol chemistry. Before assembling the quantum dots onto 
the magnetic beads using this approach, the quantum dots were immobilised onto glass 
substrate using layer-by-layer assembly, in order to characterise the immobilisation 
method using X-ray photoelectron spectroscopy and fluorescence spectroscopy (Section 
3.1).  
 
The XPS studies showed that the quantum dots were bound to the glass substrate 
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using S−Zn bonding. These studies also showed that the attachment of dithiol linker was a 
suitable means to bond successive quantum dot layers (Section 3.1.1). Moreover, 
fluorescence spectroscopy studies confirmed that as the number of layers of quantum dots 
increased, the standard deviation of the fluorescence signal for different layers remained 
low, indicating that the quantum dot layer assemblies were uniform over the substrate 
(Section 3.1.2). To test this method further, multicolour quantum dot multilayers were 
prepared on glass substrate using the same method as described above. Fluorescence 
emission spectra of these multilayers showed that signal from both types of quantum dots 
were increased as the number of layers increases, confirming the suitability of this method 
to prepare quantum dot encoded beads (Section 3.1.2). 
 
By using the dithiol linker method, two different barcodes namely (●–QD626) and 
(●–QD626QD555) were prepared onto magnetic beads (●–) (Section 3.2). It was found that 
the barcode ●-QD626 can be read optically when excited at 330-380nm (UV-2A) as 
confirmed from its characteristic emission spectrum with emission maximum at 626nm. 
However, in the presence of the second layer of quantum dots as in the case of 
●-QD626QD555, the spectral response of the first inner layer of quantum dots QD626, did not 
appear in the emission spectrum of barcode ●-QD626QD555 .  
 
It was found that QD626 emission signal appeared when excited with a 510-560 nm 
(G-2A) excitation filter. This is because QD555 outer layer is transparent to these 
wavelengths and so excitation of a fluorescent signal from QD626 can occur from the inner 
layer. However, a desirable characteristic of a barcode is that it should give signal from 
both the quantum dots simultaneously. As a consequence, this barcoding scheme was not 
pursued.  
 
It was thought that the spatial separation between different layers of quantum 
dots might be essential to produce barcodes using layer-by-layer assembly of quantum 
dots.(1) Magnetic fluorescent silica nanospheres were prepared using a thin silica shell 
(>10nm) as a spacer between different layers of quantum dots immobilised in a layer-by-
layer assembly to produce different barcodes.(1) Therefore, quantum dot-biotin and 
quantum dot-streptavidin conjugates were used to prepare barcoded beads. In these 
conjugates, CdSe/ZnS quantum dots were conjugated to streptavidin and biotin. The size 
of the quantum dot streptavidin conjugate is ~15-20nm and that of biotin conjugate is ~10-
12nm.(2, 3) When these conjugates bound in a layer-by-layer assembly, the spacing between 
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different layers of quantum dots becomes greater than 10nm.  
 
Quantum dot-biotin and quantum dot-streptavidin conjugates were subsequently 
used to prepare quantum dot barcodes using biological self-assembly in a layer-by-layer 
approach onto magnetic beads. First to test this method of immobilisation, the quantum 
dot-biotin and quantum dot-streptavidin conjugates were immobilised onto glass 
substrates and the immobilisation procedure was characterised using XPS and fluorescence 
spectroscopy (Section 3.3). First the glass slides were modified using aminosilane to 
immobilise biotin onto the glass substrate using NHS-biotin. These biotin functionalised 
glass substrates were then incubated in quantum dot-streptavidin conjugate solution to 
immobilise the first layer of quantum dots. These substrates were then incubated in 
quantum dot-biotin conjugate solution to make a second layer of quantum dots. In this 
manner ten layers of CdSe/ZnS quantum dots were formed.  
 
XPS studies showed the immobilisation of aminosilane, biotin, quantum dot-
streptavidin and quantum dot-biotin conjugates onto glass substrate. These studies 
confirmed that the immobilisation of multilayers of quantum dots is via biotin-streptavidin 
interaction (Section 3.3.1). Fluorescence spectroscopy also confirmed that the 
fluorescent signal was increased as the number of layers of quantum dot conjugates 
increased (Section 3.3.2). However, in contrast to studies involving quantum dots alone as 
described earlier using thiol chemistry, as the number of layers increases the standard 
deviation also increased. Multicolour quantum dot-conjugate multilayers were also 
prepared on glass substrate using the same method as described above. Fluorescence 
emission spectra of these multicolour multilayers showed that the signal from both types 
of quantum dots was increased as the number of layers increased with a subsequent 
increase in the standard deviation of fluorescent signal. The increase in standard deviation 
may be due to the fact that streptavidin or biotin conjugates have 5-10 or 5-7 streptavidin 
or biotin molecules on each conjugate, respectively and these varied from conjugate to 
conjugate. Therefore these films were not compact, resulting in a higher standard 
deviation of measurements on different preparations. However, the fluorescent signal 
from both the quantum dots in a multicolour multilayer assembly confirmed the suitability 
of this method to prepare quantum dot encoded beads. 
 
Quantum dot barcodes were prepared using layer-by-layer assembly of quantum 
dot-biotin and quantum dot-streptavidin conjugates onto strepatvidin magnetic beads. 
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Three different barcodes were prepared namely: ●–B605S655 ; ●–B605S655(B605S605)1 ; and 
●-B605S655(B605S605)2. Single bead fluorescence spectra of these barcodes showed that the 
barcodes can be identified on the basis of their different spectral response (Section 4.1). 
The barcodes were characterised using ratiometric measurements of fluorescence 
intensity of different quantum dot conjugates assembled on the bead surface, using the 
biological self-assembly of quantum dot biotin and quantum dot streptavidin conjugates. It 
was found that the ratiometric measurements are compararble to, and in most cases much 
better than that previously reported for quantum dot-encoded beads.(4-8)  These barcodes 
were then characterised against batch to batch difference in the preparation of barcodes 
and it was found that the batch to batch variation is negligible (Section 4.2).  
 
Biotin-streptavidin based barcodes were tested for stability at higher tempearture 
and long term stability after storage (Section 4.3). It was found that barcode information 
remained intact after heat treatment at 95°C for 15 min. In the case of long-term 
stability, barcode information was found to be intact after two month storage at 4°C. 
However, after 10 months storage, the barcode had disassembled completely giving no 
fluorescence. This may be due to the inherent instability of the quantum dot-conjugates 
immobilised onto the bead after long-term storage and quantum dot conjugates were no 
longer attached to the bead surface.  
 
As the barcodes were prepared using biological self-assembly of quantum dots 
conjugates, therefore it was important to study their stability in different concentrations 
of biotin solutuion (Section 4.3). The barcodes prepared above were incubated in 
different concentrations of biotin at room temperature and at 37°C for different time 
intervals. It was found that the barcodes were dissassembled completely in the presence 
of 100mM biotin at 37°C in 24h. This dissassembly process using different concentrations of 
biotin also confirmed that the barcode assembly was due to biotin-streptavidin 
interaction. 
 
The quantum dot barcodes as described earlier were used to develop multiplexed 
immunoassays. For this puprpose, a model immunoassay was desigened where four 
different IgGs namely: Rabbit IgG; Human IgG; Mouse IgG and ; Goat IgG were immobilised 
on four different barcodes ●–B605S655, ●–B605S655 (B605S605)1, ●-B605S605 and ●–B605S565, 
respectively. These IgGs were detected using their corresponding FITC labelled anti-IgGs 
(Section 5.1). It was found that different IgG-anti-IgG pairs can be identified on the basis 
 122
of different barcode signals. Control experiments showed that the FITC signal that 
appeared on each barcode was specific i.e. due to the specific IgG-anti-IgG pairs. 
However, a slight cross reactivity was observed among different polyclonal antibodies. As 
a control experiment, barcode ●–B605S565 without the immobilisation of any IgGs was 
incubated in a mixture of four different anti-IgGs-FITC mixture. No FITC signal was found 
on the barcode. This finding is consistent with the observation that strepatvidin can 
generate a resistant coating as is exploited in established applications that use microtitre 
plate wells for conventional immunoassays.  
 
The above experiments proved that the quantum dot barcodes prepared using 
quantum dot-biotin and quantum dot-streptavidin conjugates can be used to perform 
multiplexed immunoassays. Moreover, these barcodes were also used to perform a 
quantitative immunoassay (Section 5.2). Barcode ●–B605S655 was used to perform a 
quantitative binding inhibition immunoassay for human IgG. It was found that different 
concentrations of human IgG can be determined using these barcodes which open up a 
possibility of using these barcodes for perforrming a range of different multiplexed 
quantitative immunoassays. 
 
In future work, the barcoded technology demonstrated above could be applied 
to perform a range of clinically relevant quantitative multiplexed immunoassays and 
nucleic acid hybridisation assays. Moreover, these barcodes can also be introduced into 
different cells for intracellular studies. The present work involved the readout of the 
barcodes using single bead fluorescence spectroscopy, which is laborious and time 
consuming. These barcodes could also be read using suitably adopted flow cytometry.(6) 
The next step is the convergence of this barcode technology with the high throughput 
methods for barcode measurement and identification methods. Klostranec et al., 
developed a microfluidic system in conjunction with quantum dot encoded beads for the 
determination of different biomarkers related to hepatitis B, hepatitis C and HIV.(9) This 
system contains four main components: different quantum dot encoded beads to identify 
different target molecules; electrokinetically driven microfluidic system to enable 
sequential and high throughput readout of different barcodes; photon counting detection 
system which enables real time readout of the barcodes flowing through the microfluidic 
channels and; signal processing system for the deconvolution of the quantum dot encoded 
beads signal.(9) This type of method can be used for the high throughput readout of the 
barcode technology developed in the present studies. 
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Another route for the development of high throughput measurement system for 
these barcodes could be the patterning of the encoded beads using electrostatic or 
magnetic properties of the beads. Streptavidin coated magnetic beads were patterned at 
the micron scale using positive charge aminosilane patterns as a template for selective 
immobilisation of streptavidin coated magnetic beads.(10) Other patterning methods 
include patterning of magnetic beads using patterned polyelectrolyte multilayers, 
magnetic gradients and using PDMS stamps.(11-13) 
 
In conclusion, a new strategy to make barcodes by using biological self-assembly 
in a layer-by-layer approach is demonstrated. The analytical figures of merit for this 
technique were characterised showing the potential that the technology has for 
multiplexing immunoassays. Given the widespread use of streptavidin and biotin as ligand 
binding motifs in analytical biotechnology, the method will have broad applicability in a 
range of measurements including multiplexed immunoassays and nucleic acid hybridisation 
assays. 
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